Sleep disorders (combined)

SLEEP

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints F5_SLEEP G6_SLEEPAPNO G6_NARCOCATA G6_SLEEPDISOTH	67113
6. Filter based on genotype QC (FinnGen only)	67113

Control definitions (FinnGen only)

Control exclude: F5_BEHAVE

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	SLEEP
CONTROL_EXCLUDE	F5_BEHAVE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	F5_SLEEP\|G6_SLEEPAPNO\|G6_NARCOCATA\|G6_SLEEPDISOTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Sleep disorders (combined) based on the number of shared cases.

Similar with more cases:

Any event in hilmo or specialist outpatient

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	373804	138015	234135
Only index persons	355186	133240	221946
Unadjusted period prevalence (%)
Whole population	5.56	3.95	6.54
Only index persons	7.13	4.90	8.47
Median age at first event (years)
Whole population	53.04	54.84	51.99
Only index persons	53.04	54.93	51.91

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	67113	29598	37515
Unadjusted period prevalence (%)	13.69	10.09	16.54
Median age at first event (years)	55.50	55.50	55.50

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
33482: Matched controls
254361

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

XA420

NOMESCO Finland

Extensive sleep examination

34.6

323.0

757

170

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.7

323.0

1846

3979

R03DC03

ATC

montelukast; oral

2.0

323.0

5893

24219

J01DB01

ATC

cefalexin; oral

1.9

323.0

26845

172933

R06.0

ICD-10 Finland

Dyspnoea

2.4

323.0

8983

33285

H02AB06

ATC

prednisolone; systemic

1.8

323.0

15381

80728

R03AK07

ATC

formoterol and budesonide; inhalant

1.9

323.0

6379

28466

R03AC02

ATC

salbutamol; inhalant

2.2

323.0

19584

99439

N06AX11

ATC

mirtazapine; oral

2.5

323.0

12707

49956

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.9

323.0

6546

28408

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

4.9

323.0

1811

2917

N05BA04

ATC

oxazepam; oral

2.2

323.0

9406

38203

N06AX21

ATC

duloxetine; oral

3.2

323.0

4948

13237

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.4

323.0

3518

11961

SPAT1094

SPAT

Continuous Positive Airway Pressure

128.0

323.0

822

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

4.9

323.0

1649

2634

E66.9

ICD-10 Finland

Obesity, unspecified

6.1

323.0

1882

2462

M79.6

ICD-10 Finland

Pain in limb

1.9

323.0

12080

59315

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.9

323.0

5489

16065

M25.5

ICD-10 Finland

Pain in joint

1.7

323.0

9420

46911

SPAT1377

SPAT

Polysomnography

12.0

323.0

2322

1568

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.5

323.0

5002

16570

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

323.0

5848

24668

M54.5

ICD-10 Finland

Low back pain

1.8

323.0

11227

54688

G47.3

ICD-10 Finland

Sleep apnoea

387.7

323.0

27182

2831

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.4

323.0

7187

26420

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

5.5

323.0

1352

1925

E66.8

ICD-10 Finland

Other obesity

7.0

323.0

3512

4214

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.9

323.0

2091

4278

103

Kela drug reimbursment

Diabetes, insulin-treated

2.2

323.0

7663

29925

T90

ICPC

Diabetes non-insulin dependent

2.5

323.0

6822

23686

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

323.0

11713

60289

A10BK03

ATC

empagliflozin; oral

3.2

323.0

1983

4835

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.4

323.0

4264

14560

L17

ICPC

Foot/toe symptom/complaint

1.8

323.0

7820

37573

N03AX09

ATC

lamotrigine; oral

3.3

323.0

1979

4799

A10BJ06

ATC

semaglutide; parenteral

5.1

323.0

1150

1769

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

2.4

323.0

3961

13712

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

+∞

323.0

888

T82

ICPC

Obesity

6.5

323.0

2273

2808

R06.5

ICD-10 Finland

Mouth breathing

11.1

323.0

5864

4757

I10

ICD-10 Finland

Essential (primary) hypertension

2.2

323.0

17123

82512

R02

ICPC

Shortness of breath/dyspnoea

2.2

323.0

3952

14383

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

323.0

3780

13788

A10BA02

ATC

metformin; oral

2.4

323.0

8371

30513

C08CA01

ATC

amlodipine; oral

1.8

323.0

9291

44303

L03

ICPC

Low back symptom/complaint

1.8

323.0

8143

37730

M01AB05

ATC

diclofenac; systemic, rectal

1.6

323.0

20949

128290

SPAT1262

SPAT

Handing over of treatment supplies

2.4

323.0

5653

20033

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

323.0

22972

144224

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

323.0

13150

63605

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

7.8

323.0

1148

1152

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.2

323.0

2769

7060

A02BC05

ATC

esomeprazole; systemic

1.8

323.0

13361

67784

R53

ICD-10 Finland

Malaise and fatigue

2.2

323.0

7507

29637

N03AX12

ATC

gabapentin; oral

2.2

323.0

5246

19805

N06AB06

ATC

sertraline; oral

2.5

323.0

4322

14253

SPAT1263

SPAT

Sampling

1.7

323.0

13768

75586

P06

ICPC

Sleep disturbance

5.1

323.0

5763

9885

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

323.0

8045

35976

R01AD09

ATC

mometasone; nasal

1.9

323.0

16417

84244

E66.00

ICD-10 Finland

Metabolic syndrome

5.7

323.0

2456

3471

A06AC01

ATC

ispaghula (psylla seeds); oral

1.9

323.0

8021

36609

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.5

323.0

6782

23433

G47.9

ICD-10 Finland

Sleep disorder, unspecified

13.7

323.0

1727

1006

F51.0

ICD-10 Finland

Nonorganic insomnia

3.9

323.0

7291

16835

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.5

323.0

3494

11372

E66.01

ICD-10 Finland

Obesity due to excess calories

6.1

323.0

5181

7377

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.1

323.0

7928

33410

J45.9

ICD-10 Finland

Asthma, unspecified

2.5

323.0

6901

24173

M01AH05

ATC

etoricoxib; oral

1.7

323.0

18830

108974

N02BE01

ATC

paracetamol; systemic, rectal

2.2

323.0

28474

182735

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.7

323.0

2640

5808

C03CA01

ATC

furosemide; systemic

2.0

323.0

7938

34373

R5140

NOMESCO Finland

Monitoring the use of the aid

40.2

323.0

9981

2657

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

323.0

16355

96196

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

323.0

15037

86623

N06AX26

ATC

vortioxetine; oral

3.2

323.0

2399

6062

J01AA02

ATC

doxycycline; systemic

1.9

323.0

25388

159314

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.0

323.0

5805

24006

E66

ICD-10 Finland

Obesity

5.1

323.0

2265

3571

WX110

NOMESCO Finland

Local anesthesy

1.6

323.0

22211

139397

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

323.0

7508

30299

N02AX02

ATC

tramadol; systemic, rectal

1.9

323.0

13349

65348

N04BC05

ATC

pramipexole; oral

2.8

323.0

2516

7271

N06AB04

ATC

citalopram; systemic

2.4

323.0

8610

31882

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.8

323.0

3506

10092

R01AD12

ATC

fluticasone furoate; nasal

1.8

323.0

10759

51989

C07AB07

ATC

bisoprolol; oral

1.9

323.0

13593

67227

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

323.0

14737

78869

N06AX16

ATC

venlafaxine; oral

3.1

323.0

6533

18641

M03BX02

ATC

tizanidine; oral

1.8

323.0

20576

120108

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.9

323.0

7503

34303

N06AB10

ATC

escitalopram; oral

2.3

323.0

8266

31303

H03AA01

ATC

levothyroxine sodium; systemic

1.8

323.0

8253

39979

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

18.9

323.0

639

261

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

323.0

12013

62594

N05CF02

ATC

zolpidem; oral

2.1

323.0

6423

26005

WX780

NOMESCO Finland

Remote monitoring CPAP

1456.9

323.0

3952

SPAT1310

SPAT

Counselling related to known health issue

1.7

323.0

10203

51836

WX722

NOMESCO Finland

PEEP

25.1

323.0

3287

1097

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

323.0

9147

41448

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

15.0

323.0

9524

6554

R01AD08

ATC

fluticasone; nasal

1.8

323.0

9870

48696

N05AH04

ATC

quetiapine; oral

3.1

323.0

7469

21566

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.9

323.0

9447

43192

N06AB03

ATC

fluoxetine; oral

2.6

323.0

5026

16014

N06AA09

ATC

amitriptyline; systemic

2.3

323.0

3475

12082

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

323.0

13284

69667

N03AX16

ATC

pregabalin; oral

2.2

323.0

8187

33255

N06AX12

ATC

bupropion; oral

3.9

323.0

3092

6466

N05CF01

ATC

zopiclone; oral

2.0

323.0

10831

49347

A02BC03

ATC

lansoprazole; oral

1.7

323.0

8980

45001

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.9

323.0

2204

4570

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.6

323.0

17675

103310

A02BC02

ATC

pantoprazole; systemic

2.0

323.0

21581

120279

WX723

NOMESCO Finland

CPAP therapy

706.7

323.0

3505

XG466

NOMESCO Finland

Sleep oxymetry

22.5

323.0

2354

851

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

6.9

321.1

890

1007

EB1MA

NOMESCO Finland

Cephalometry with X-ray

5.6

318.2

1032

1438

R03BA05

ATC

fluticasone; inhalant

1.8

317.5

6226

27952

P03

ICPC

Feeling depressed

2.3

316.7

3458

12230

P76

ICPC

Depressive disorder

2.7

311.8

2460

7309

R06AE07

ATC

cetirizine; oral

1.6

311.1

14741

84998

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.3

310.5

3213

11063

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.7

309.2

9405

48315

C10AA05

ATC

atorvastatin; oral

1.7

305.2

9151

46785

SPAT1240

SPAT

Therapeutic discussion

2.1

303.7

3947

15095

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

302.6

15331

89614

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

301.1

18140

110389

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.0

300.5

4478

18117

R04

ICPC

Breathing problem other

4.1

300.1

1321

2545

UJF32

NOMESCO Finland

Coloscopy

1.7

298.9

7459

36099

R03BB04

ATC

tiotropium bromide; inhalant

2.4

294.9

2879

9611

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

294.6

12445

69459

N05AH03

ATC

olanzapine; systemic

2.8

294.1

2186

6257

3074A

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Specific disorders of sleep of nonorganic origin[UNIHÄIRIÖ]

+∞

293.0

313

N06AX05

ATC

trazodone; oral

4.5

291.2

1146

1980

R51.80

ICD-10 Finland

Headache

1.9

291.1

5123

22055

N05AX12

ATC

aripiprazole; systemic

3.4

289.9

1608

3762

L15

ICPC

Knee symptom/complaint

1.8

289.3

6443

30049

S18

ICPC

Laceration/cut

1.6

288.8

11865

65670

C09CA01

ATC

losartan; oral

1.8

288.5

6322

29328

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

288.5

7671

37772

C09CA06

ATC

candesartan; oral

1.8

288.3

6323

29339

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.8

287.0

6657

31439

M01AE02

ATC

naproxen; oral, rectal

1.5

286.9

17976

109812

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

284.6

5054

21811

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.8

284.2

5780

26144

J45

ICD-10 Finland

Asthma

2.2

284.0

3405

12541

SBB10

NOMESCO Finland

Teeth copy

2.7

283.4

2263

6757

M79.7

ICD-10 Finland

Fibromyalgia

3.4

282.3

1552

3605

A02BC01

ATC

omeprazole; systemic

1.7

280.9

8241

41680

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

280.2

7648

37888

R03BA02

ATC

budesonide; inhalant

1.8

279.5

5862

26770

F34.1

ICD-10 Finland

Dysthymia

3.5

279.1

1456

3244

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.2

278.8

3453

12896

K02.1

ICD-10 Finland

Caries of dentine

1.5

276.0

17958

110190

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.9

275.5

4819

20658

N05BA12

ATC

alprazolam; oral

2.1

269.2

3437

12994

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

268.4

13143

75448

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

268.1

8958

46816

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

267.7

16647

100812

J01FA10

ATC

azithromycin; systemic

1.5

267.7

19088

119127

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

266.5

5171

22966

N05BA01

ATC

diazepam; systemic, rectal

2.0

266.2

4188

17239

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

266.2

20674

131397

SPAT1051

SPAT

Guidance regarding sleep disorders

6.9

264.3

728

815

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.0

264.3

4152

17077

J01DA01

ATC

[U] cefalexin; systemic

1.5

263.5

19985

126201

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

262.8

12238

69334

R05

ICD-10 Finland

Cough

1.8

262.7

5959

27839

J01FA06

ATC

roxithromycin; oral

1.5

262.0

12683

72485

J01FF01

ATC

clindamycin; systemic

1.6

260.5

8058

41190

N06AX03

ATC

mianserin; oral

3.0

260.4

1692

4429

C07AA05

ATC

propranolol; systemic

1.7

259.2

6453

31001

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.0

259.1

3788

15137

C10AA01

ATC

simvastatin; oral

1.6

259.1

10204

55494

P01AB01

ATC

metronidazole; oral, rectal

1.5

258.5

12812

73547

A10BH01

ATC

sitagliptin; oral

2.4

258.1

2427

7921

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.5

256.8

2296

7296

L28

ICPC

Limited function/disability (L)

1.9

255.2

4472

19135

A10BJ02

ATC

liraglutide; parenteral

5.5

252.9

826

1159

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.4

251.7

2519

8485

J01CA04

ATC

amoxicillin; systemic

1.6

251.4

26358

178041

G44.2

ICD-10 Finland

Tension-type headache

1.9

250.4

4559

19763

AA40B

NOMESCO Finland

149.7

250.0

293

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.8

249.5

1839

5221

C10AA07

ATC

rosuvastatin; oral

1.7

249.0

5962

28262

J31.0

ICD-10 Finland

Chronic rhinitis

2.3

248.1

2636

9143

J02AC01

ATC

fluconazole; systemic

1.5

245.7

14043

82887

N06AB05

ATC

paroxetine; oral

2.5

245.5

2185

6920

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

4.9

244.8

887

1402

R96

ICPC

Asthma

2.2

244.7

2866

10403

205

Kela drug reimbursment

Chronic hypertension

1.7

243.0

6560

32185

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

242.8

10932

61134

R03BA08

ATC

ciclesonide; inhalant

2.2

239.7

2807

10186

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

4.1

239.2

1026

1925

M01AC06

ATC

meloxicam; systemic, rectal

1.5

239.1

10940

61349

N05CD07

ATC

temazepam; oral

2.0

236.6

3445

13713

R42

ICD-10 Finland

Dizziness and giddiness

1.7

236.1

6296

30743

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.7

236.1

1806

5241

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

234.8

5145

23673

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

233.3

12392

71724

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.5

233.2

11690

66805

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.0

232.3

1480

3815

J45.1

ICD-10 Finland

Nonallergic asthma

2.4

231.8

2312

7762

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

231.3

9741

53484

WX290

NOMESCO Finland

Other blockade of nerve

1.5

231.2

13845

82152

R60.0

ICD-10 Finland

Localized oedema

2.1

230.9

3176

12344

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.6

230.2

7751

40280

AA1AD

NOMESCO Finland

CT of head and brain

1.7

229.3

6226

30526

J34.2

ICD-10 Finland

Deviated nasal septum

3.0

228.5

1473

3828

R05

ICPC

Cough

1.6

228.4

6895

34803

F32

ICD-10 Finland

Depressive episode

2.5

227.8

1951

6040

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

226.4

5052

23351

SPAT1260

SPAT

Consultation of another employee

1.7

225.3

5310

24957

Z01.2

ICD-10 Finland

Dental examination

1.5

224.9

12794

74955

M02AA07

ATC

piroxicam; topical

1.5

224.7

10500

58942

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

224.7

9843

54453

G47.1

ICD-10 Finland

Disorders of excessive somnolence [hypersomnias]

197.8

224.3

258

F32.1

ICD-10 Finland

Moderate depressive episode

2.5

223.8

2011

6391

M70.6

ICD-10 Finland

Trochanteric bursitis

1.9

223.0

3948

16886

SPAT1312

SPAT

General health counselling

1.5

222.8

9813

54327

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.1

221.5

2993

11536

R03AK08

ATC

formoterol and beclometasone; inhalant

3.1

220.9

1365

3443

N03AG01

ATC

valproic acid; systemic, rectal

2.5

220.4

2024

6506

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

219.7

11817

68308

N05AA02

ATC

levomepromazine; systemic

3.2

219.4

1319

3263

R03BA01

ATC

beclometasone; inhalant

1.8

218.4

4476

20109

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.0

217.1

3015

11748

L08

ICPC

Shoulder symptom/complaint

1.7

215.7

5332

25383

DHB50

NOMESCO Finland

Turbinoplasty

4.0

215.6

961

1867

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

4.1

215.0

939

1790

R03AC03

ATC

terbutaline; inhalant

1.8

214.7

4607

20996

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.8

214.5

4134

18188

M79.1

ICD-10 Finland

Myalgia

1.8

213.5

4126

18166

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

213.3

2878

11077

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.7

212.0

1049

2232

P01

ICPC

Feeling anxious/nervous/tense

1.9

210.1

3555

14935

R05FB02

ATC

cough suppressants and expectorants

1.5

210.0

11212

64533

N03AE01

ATC

clonazepam; systemic

2.5

209.7

1893

6025

J01FA09

ATC

clarithromycin; systemic

1.5

209.6

9846

55124

D07AC01

ATC

betamethasone; topical

1.5

209.4

9824

54982

A02BA02

ATC

ranitidine; systemic

1.7

207.2

5544

26966

N06AX22

ATC

agomelatine; oral

4.1

206.6

901

1715

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

206.1

4164

18589

A04

ICPC

Weakness/tiredness general

1.8

206.0

3987

17549

R06AX27

ATC

desloratadine; oral

1.5

205.5

8907

48926

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.8

204.6

4567

21044

R99

ICPC

Respiratory disease other

5.6

204.4

657

903

SPAT1153

SPAT

Removal of sutures

1.5

204.4

8698

47570

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

3.3

203.9

1156

2738

N06AA12

ATC

doxepin; systemic

2.6

202.2

1671

5061

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.1

201.7

2671

10189

XA421

NOMESCO Finland

Nocturnal polygraphy

42.3

201.5

276

SPAT1301

SPAT

No procedures

1.5

200.4

9211

51204

E0000UV

ATC

1.5

197.8

12119

71495

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.0

197.5

3056

12403

SPAT1058

SPAT

PEF monitoring instruction

2.1

197.1

2521

9474

A46

ICD-10 Finland

Erysipelas

1.9

195.5

3375

14255

L01

ICPC

Neck symptom/complaint

1.8

195.5

4287

19620

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

194.1

6532

33700

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.5

193.5

1698

5315

C08CA13

ATC

lercanidipine; oral

1.9

192.3

3265

13705

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.7

191.3

1508

4442

M01AH01

ATC

celecoxib; oral (coxibs)

1.7

191.3

5227

25511

B01AB05

ATC

enoxaparin; parenteral

1.5

189.6

8199

44848

ENC30

NOMESCO Finland

Plastic operation of pharynx

9.7

189.1

421

332

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

188.8

3433

14759

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

187.9

9111

51079

160

Kela drug reimbursment

exenatide

5.2

186.5

644

964

C03DA01

ATC

spironolactone; oral

2.0

185.5

2617

10231

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.0

185.1

2825

11388

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

184.9

2879

11696

ENC40

NOMESCO Finland

Uvulopalatopharyngoplasty

15.5

183.1

330

163

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

182.8

5082

24884

SPAT1097

SPAT

Recording of ECG

1.8

182.4

3874

17519

M04AA01

ATC

allopurinol; systemic

2.0

182.2

2614

10282

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.2

182.1

1080

2641

C09DA01

ATC

losartan and diuretics; oral

2.0

181.3

2617

10321

J01MA12

ATC

levofloxacin; systemic

1.7

179.1

4804

23277

N05AX08

ATC

risperidone; systemic

2.1

179.0

2262

8440

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.4

178.1

976

2251

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

178.0

6613

34843

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

177.5

3351

14569

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

4.2

177.5

748

1378

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.7

176.9

4531

21661

G04BD12

ATC

mirabegron; oral

2.0

176.5

2637

10532

M01AX17

ATC

nimesulide; oral

1.5

175.0

6643

35158

-1

NOMESCO Finland

1.4

174.3

10245

59527

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.4

173.6

931

2111

I50.9

ICD-10 Finland

Heart failure, unspecified

1.9

173.6

2891

12026

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.8

173.6

3232

13983

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.5

173.3

1474

4530

F50.9

ICD-10 Finland

Eating disorder, unspecified

27.3

172.4

260

XG410

NOMESCO Finland

Flow-volume spirometry

2.8

171.4

1251

3514

P29

ICPC

Psychological sympt/compl other

2.2

171.3

1916

6766

R74

ICPC

Upper respiratory infection acute

1.5

170.9

9194

52438

R01AD01

ATC

beclometasone; nasal

1.6

170.8

4766

23316

H02AB04

ATC

methylprednisolone; systemic

1.7

168.9

4284

20397

T83

ICPC

Overweight

4.0

168.7

758

1482

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

168.5

3620

16398

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

167.7

5793

29929

C07AB02

ATC

metoprolol; systemic

1.6

167.5

5191

26094

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

3.2

166.1

955

2283

J20

ICD-10 Finland

Acute bronchitis

1.9

165.8

2849

11975

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

164.5

6968

37729

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.7

163.8

1236

3543

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

163.7

9382

54084

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.8

163.4

3488

15759

SPAT1254

SPAT

Administration of medicine

1.7

163.2

4032

19038

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.9

163.1

2787

11687

C09AA02

ATC

enalapril; systemic

1.6

162.5

4594

22523

ZXC60

NOMESCO Finland

Application of heat

5.2

161.9

553

817

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.0

161.7

717

1385

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

161.0

2059

7709

M01AX05

ATC

glucosamine; oral

1.6

160.9

5239

26642

R4190

NOMESCO Finland

Nutritional therapy

3.0

160.9

1037

2687

L16

ICPC

Ankle symptom/complaint

1.8

160.7

2998

12958

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.0

160.6

2350

9298

F61.0

ICD-10 Finland

Mixed personality disorders

4.1

160.5

688

1288

M48.0

ICD-10 Finland

Spinal stenosis

1.8

160.4

2931

12580

L13

ICPC

Hip symptom/complaint

1.7

158.9

4321

20948

C03AA03

ATC

hydrochlorothiazide; oral

1.9

158.2

2475

10042

M01AE01

ATC

ibuprofen; systemic, rectal

1.5

157.9

28583

201742

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

157.8

12051

73129

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

3.4

157.4

855

1958

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

157.3

2461

9986

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

157.2

3814

17897

G47.4

ICD-10 Finland

Narcolepsy and cataplexy

436.7

155.1

172

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

154.9

2954

12854

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

154.5

21319

142622

A10BK01

ATC

dapagliflozin; oral

2.9

154.5

1057

2847

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.3

154.2

848

1960

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.8

154.1

716

1442

N06AG02

ATC

moclobemide; oral

2.5

153.7

1341

4173

J96.1

ICD-10 Finland

Chronic respiratory failure

4.3

153.6

627

1120

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

153.6

2039

7753

XF402

NOMESCO Finland

ECG with work load test

1.9

153.4

2645

11115

KMAK

NOMESCO Finland

1.4

152.9

16023

102382

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

152.7

2552

10605

UKC02

NOMESCO Finland

Cystoscopy

1.7

152.7

3540

16380

WZA90

NOMESCO Finland

Other doctors statement

1.5

152.7

6648

36117

H02AB07

ATC

prednisone; oral

1.7

152.4

4084

19702

D82

ICPC

Teeth/gum disease

1.4

151.6

10314

61186

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

151.2

7864

44324

N06AA06

ATC

trimipramine; systemic

3.3

150.9

836

1943

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.8

150.7

708

1439

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.4

150.7

10727

64136

N05BE01

ATC

buspirone; oral

3.1

149.9

902

2227

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

218.6

149.7

171

G47.2

ICD-10 Finland

Disorders of the sleep-wake schedule

34.6

149.6

213

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

149.0

4191

20471

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.1

148.8

1866

6924

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

148.5

5159

26592

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.9

148.1

2326

9443

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.1

147.6

1877

7006

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.0

147.4

951

2465

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.7

147.3

1149

3354

R52.9

ICD-10 Finland

Pain, unspecified

1.9

146.6

2427

10046

M02AA10

ATC

ketoprofen; topical

1.6

145.0

4393

21871

J01MA02

ATC

ciprofloxacin; systemic

1.4

145.0

10207

60802

C09AA05

ATC

ramipril; oral

1.5

144.8

5293

27597

SPAT1216

SPAT

Assessment of functional ability

1.6

143.8

3930

19034

OAB72

NOMESCO Finland

Weight control and weight loss guidance

9.0

143.8

334

285

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

143.4

8129

46504

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

142.9

7737

43861

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.7

142.8

3269

15047

D11

ICPC

Diarrhoea

1.7

142.7

3453

16155

R29

ICPC

Respiratory symptom/complaint other

2.1

141.5

1868

7078

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

140.2

15291

97765

F51.2

ICD-10 Finland

Nonorganic disorder of the sleep-wake schedule

9.5

139.6

314

253

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

139.1

2935

13173

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

138.6

4912

25392

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

138.5

6675

36932

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

137.9

3611

17268

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

136.9

4824

24897

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.7

136.8

3281

15301

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

5.3

136.6

458

663

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.9

136.4

2198

8998

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.7

135.3

656

1370

M01AH02

ATC

rofecoxib; oral

1.7

135.0

3480

16560

SPAT1229

SPAT

Assessment of need for aid

1.9

134.9

2096

8465

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.4

134.7

1257

4053

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.1

134.5

579

1088

M54

ICD-10 Finland

Dorsalgia

1.7

134.5

3291

15431

A10AE04

ATC

insulin glargine; parenteral

1.9

134.4

2205

9082

F33

ICD-10 Finland

Recurrent depressive disorder

3.3

134.2

735

1693

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.2

133.8

769

1836

SPAT1139

SPAT

Nutrition survey

2.7

133.7

1011

2897

A01

ICPC

Pain general/multiple sites

1.9

133.4

2189

9020

D07AC13

ATC

mometasone; topical

1.4

132.1

8057

46589

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.4

131.6

1229

3963

N05AF03

ATC

chlorprothixene; systemic

3.0

131.5

835

2140

K30

ICD-10 Finland

Functional dyspepsia

1.7

131.4

3046

14053

N05AN01

ATC

lithium; oral

3.1

131.3

799

1988

R06AX22

ATC

ebastine; oral

1.5

131.3

5324

28349

R07.3

ICD-10 Finland

Other chest pain

1.8

131.3

2472

10683

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.5

131.2

685

1520

P99

ICPC

Psychological disorders other

2.8

131.1

917

2504

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

130.9

4441

22688

R03AC13

ATC

formoterol; inhalant

2.2

130.6

1486

5275

DJD20

NOMESCO Finland

Plastic repair of septum of nose

2.9

130.2

865

2284

SPAT1211

SPAT

Application of soft bandage

1.8

130.0

2480

10759

A10BX07

ATC

[U] liraglutide; parenteral

5.7

129.6

408

547

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

129.0

4898

25684

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.9

128.8

2258

9520

WZC30

NOMESCO Finland

Teaching

1.7

127.9

3292

15645

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

127.6

2056

8410

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.4

127.3

1238

4073

G04BD08

ATC

solifenacin; oral

2.0

126.3

1757

6792

C09CA03

ATC

valsartan; oral

1.9

126.1

2004

8153

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.9

125.7

2060

8477

F50.2

ICD-10 Finland

Bulimia nervosa

31.0

125.5

183

A02BC04

ATC

rabeprazole; oral

1.8

125.4

2432

10605

SPAT1281

SPAT

Other administrative function

1.9

125.2

2217

9377

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

125.2

3149

14865

R06.2

ICD-10 Finland

Wheezing

2.3

124.8

1286

4354

C09DA06

ATC

candesartan and diuretics; oral

2.0

124.6

1746

6767

S29

ICPC

Skin symptom/complaint other

1.5

124.1

4460

23073

N06BA04

ATC

methylphenidate; oral

3.0

124.1

801

2074

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

123.5

2070

8584

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

123.5

1323

4563

A98

ICPC

Health maint/preventive medicine

1.7

122.9

31395

228666

J46

ICD-10 Finland

Status asthmaticus

2.8

122.6

897

2517

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.0

122.5

1657

6331

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.6

122.2

3258

15624

ACC51

NOMESCO Finland

Release of median nerve

1.9

122.1

2082

8687

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.3

121.4

1292

4443

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.8

121.3

2462

10891

WX002

NOMESCO Finland

Sedation and analgesia

1.5

121.0

5066

27106

F50.3

ICD-10 Finland

Atypical bulimia nervosa

52.8

121.0

159

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.7

120.6

2810

12966

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

4.1

120.2

515

964

R60.9

ICD-10 Finland

Oedema, unspecified

2.2

120.0

1313

4573

E66.0

ICD-10 Finland

Obesity due to excess calories

5.4

119.8

398

570

R35

ICD-10 Finland

Polyuria

2.2

119.8

1418

5118

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

119.7

7097

40692

N05AB03

ATC

perphenazine; systemic, rectal

2.5

119.7

1035

3200

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.9

119.4

543

1073

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.6

119.0

584

1232

162

Kela drug reimbursment

liraglutide

5.9

119.0

365

474

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.4

118.9

644

1471

B01AA03

ATC

warfarin; systemic

1.6

118.8

4114

21078

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

118.2

14036

89992

F51

ICD-10 Finland

Nonorganic sleep disorders

2.4

118.1

1142

3745

4471

FHL

Pharyngoplasty

31.8

118.0

171

SGA01

NOMESCO Finland

Tooth opening as first aid

1.5

117.9

4423

23086

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.5

117.8

1022

3167

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.5

117.5

5209

28194

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

117.5

2814

13085

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

3.0

117.3

754

1948

N03AX11

ATC

topiramate; oral

2.7

116.3

883

2536

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.0

115.7

749

1944

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.3

114.7

1138

3779

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

114.6

3387

16672

L02

ICPC

Back symptom/complaint

1.7

114.4

2637

12120

XQ800

NOMESCO Finland

Prick test

1.8

114.4

2346

10404

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.1

114.3

705

1769

7849C

ICD-9 Finland

Symptoms involving head and neck, Other symptoms involving head and neck[KUORSAUS]

8.4

114.3

275

250

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

114.3

2323

10273

R03AK11

ATC

formoterol and fluticasone; inhalant

2.9

113.3

779

2102

207

Kela drug reimbursment

Chronic arrhythmias

1.7

113.3

2843

13388

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

3.6

113.2

567

1217

F50.8

ICD-10 Finland

Other eating disorders

38.6

113.0

157

Z71.8

ICD-10 Finland

Other specified counselling

1.4

113.0

6816

39136

R00.2

ICD-10 Finland

Palpitations

1.8

112.9

2131

9198

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.7

112.6

2860

13513

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

112.3

1759

7112

P74

ICPC

Anxiety disorder/anxiety state

2.2

111.6

1196

4123

R06AE09

ATC

levocetirizine; oral

1.5

111.0

4378

23073

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.8

111.0

516

1040

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

4.0

110.9

489

940

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

3.5

110.6

568

1244

K04.0

ICD-10 Finland

Pulpitis

1.7

110.6

2769

13026

SPAT1059

SPAT

Spirometry at the office

2.1

110.5

1367

5028

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

110.3

4276

22452

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

110.1

5149

28135

G43.9

ICD-10 Finland

Migraine, unspecified

1.9

109.7

1867

7775

D07AD01

ATC

clobetasol; topical

1.5

109.4

4143

21637

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.4

109.2

1029

3329

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

109.1

3796

19436

SPAT1104

SPAT

Monitoring of emergency patient

1.9

108.8

1699

6857

Z01.9

ICD-10 Finland

Special examination, unspecified

2.0

108.2

1510

5837

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.4

108.1

1033

3367

SCA04

NOMESCO Finland

Guidance on care of mouth and oral mucosa

29.6

108.0

159

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

107.7

6195

35213

W78

ICPC

Pregnancy

0.6

107.2

1413

18523

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

107.1

1426

5407

C02AC05

ATC

moxonidine; oral

2.4

107.1

993

3187

3478X

ICD-9 Finland

Cataplexy and narcolepsy[MUUT ORGANISET UNIHÄIRIÖT]

+∞

106.6

114

EBA00

NOMESCO Finland

Extraction of tooth

1.3

106.4

8818

53317

R52.2

ICD-10 Finland

Other chronic pain

2.4

106.4

979

3128

XF404

NOMESCO Finland

Ambulatory ECG

1.8

106.3

2197

9757

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

105.8

1922

8182

JDF01

NOMESCO Finland

Laparoscopic gastroplasty

7.8

105.0

265

261

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.5

104.8

886

2705

R13

ICD-10 Finland

Dysphagia

1.9

104.7

1614

6483

D01

ICPC

Abdominal pain/cramps general

1.6

104.5

3037

14863

C05AA08

ATC

fluocortolone; rectal, topical

1.5

104.2

3720

19145

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

103.8

2697

12808

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

3.7

103.7

491

1006

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.7

103.6

504

1056

SDA02

NOMESCO Finland

Parodonthologic therapy

1.3

103.6

9342

57177

N06AX18

ATC

reboxetine; oral

4.3

103.4

421

751

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.6

103.4

827

2448

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

102.7

4819

26311

L86

ICPC

Back syndrome with radiating pain

2.0

102.6

1538

6111

L14

ICPC

Leg/thigh symptom/complaint

1.8

102.5

1913

8215

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.8

102.3

2102

9313

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.6

102.0

3242

16222

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.7

101.8

2300

10493

GX2D5

NOMESCO Finland

Sleep oximetry

16.0

101.5

180

L90

ICPC

Osteoarthrosis of knee

1.9

101.3

1534

6118

LCA06

NOMESCO Finland

Biopsy of endometrium

1.5

101.3

3924

20564

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.6

101.3

3000

14747

M10.9

ICD-10 Finland

Gout, unspecified

2.2

101.2

1107

3852

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.8

101.1

1926

8327

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.7

100.8

2289

10456

M54.6

ICD-10 Finland

Pain in thoracic spine

1.8

99.4

1916

8316

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

99.3

4313

23160

R01AD11

ATC

triamcinolone; nasal

1.7

99.0

2569

12188

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

98.9

4255

22799

A06AD11

ATC

lactulose; oral

1.6

98.5

3319

16839

R11

ICD-10 Finland

Nausea and vomiting

1.7

98.4

2171

9830

R03AC12

ATC

salmeterol; inhalant

2.1

98.3

1246

4628

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

98.1

2966

14649

J45.8

ICD-10 Finland

Mixed asthma

2.4

97.9

891

2832

G04BD04

ATC

oxybutynin; oral, transdermal

1.9

97.5

1476

5884

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.9

97.4

1522

6140

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

97.3

1776

7567

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

97.1

3380

17275

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

97.0

1295

4913

D01BA02

ATC

terbinafine; oral; topical

1.4

97.0

5765

32875

A08

ICPC

Swelling

2.2

96.8

1083

3805

UDC00

NOMESCO Finland

Ear microscopy

1.8

96.7

1855

8035

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

96.7

7729

46323

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

96.5

2390

11188

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

96.4

3194

16129

N17

ICPC

Vertigo/dizziness

1.6

96.2

2843

13957

A03FA02

ATC

cisapride; oral, rectal

1.7

96.1

2027

9049

R51

ICD-10 Finland

Headache

1.9

96.1

1546

6303

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.7

96.0

2168

9884

N05BA06

ATC

lorazepam; systemic, sublingual

2.0

95.8

1288

4900

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

95.5

3939

20904

F45.8

ICD-10 Finland

Other somatoform disorders

1.7

95.4

2126

9652

C01DA14

ATC

isosorbide mononitrate; oral

1.6

94.6

2950

14674

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.2

94.5

1019

3522

SPAT1053

SPAT

Memory test

1.6

94.4

3083

15514

C10AX09

ATC

ezetimibe; oral

1.7

94.3

2097

9514

N39.3

ICD-10 Finland

Stress incontinence

1.7

93.8

2226

10290

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

4.0

93.8

409

779

SPAT1197

SPAT

Extensive health check-up of expecting family

0.6

93.7

1287

16723

L29

ICPC

Musculoskeletal sympt/complt other

1.7

93.7

1977

8825

SPAT1307

SPAT

Psychosocial counselling and guidance

1.8

93.7

1840

8030

R21

ICPC

Throat symptom/complaint

1.4

93.4

5975

34488

A03

ICPC

Fever

1.4

93.3

4562

25058

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

93.3

3034

15247

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.4

92.9

6369

37190

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.6

92.6

2513

12060

RD210

NOMESCO Finland

3.1

92.5

559

1383

S10

ICPC

Boil/carbuncle

2.0

92.4

1379

5466

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.0

92.3

1278

4921

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.5

92.1

4077

21944

B02AA02

ATC

tranexamic acid; systemic

1.4

91.9

4759

26424

A10BX04

ATC

[U] exenatide; parenteral

5.2

91.7

309

451

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

91.4

3942

21105

K85

ICPC

Elevated blood pressure

1.5

91.3

3429

17816

K07.4

ICD-10 Finland

Malocclusion, unspecified

3.1

91.0

539

1316

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.3

90.4

891

2948

E000001

ATC

1.4

90.3

5759

33194

B01AF01

ATC

rivaroxaban; oral

1.6

90.2

2475

11908

SXC06

NOMESCO Finland

Clinical work to produce sleep apnoea splint

28.4

90.2

134

R03DA04

ATC

theophylline; systemic, rectal

2.0

90.1

1300

5086

L12

ICPC

Hand/finger symptom/complaint

1.5

90.1

3800

20244

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

90.1

2050

9359

N01

ICPC

Headache

1.6

90.0

2990

15096

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.7

89.8

3353

35293

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

89.8

2359

11219

B01AF02

ATC

apixaban; oral

1.7

89.6

1925

8637

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

89.5

1707

7377

A10BH05

ATC

linagliptin; oral

2.2

89.4

978

3402

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

89.0

2237

10507

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.9

89.0

1437

5862

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.0

88.8

1320

5223

K04.1

ICD-10 Finland

Necrosis of pulp

1.6

88.4

2695

13322

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.6

88.1

729

2200

RK320

NOMESCO Finland

5.9

88.0

268

346

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.5

87.9

770

2396

ZXA10

NOMESCO Finland

Bilateral

1.4

87.9

4800

26897

WX320

NOMESCO Finland

Spinalanesthesy

1.4

87.9

5628

32442

XKD00

NOMESCO Finland

Uroflowmetry

1.6

87.8

2304

10952

M54.2

ICD-10 Finland

Cervicalgia

1.7

87.5

1891

8499

G47.8

ICD-10 Finland

Other sleep disorders

4.8

87.5

320

512

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.7

87.5

4396

44108

J01MA14

ATC

moxifloxacin; systemic

1.7

87.1

2139

9979

N07BA03

ATC

varenicline; oral

2.0

87.1

1298

5141

SPAT1380

SPAT

Postpartum check-up

0.5

86.4

753

11111

S06.0

ICD-10 Finland

Concussion

1.6

86.4

2658

13165

R32

ICD-10 Finland

Unspecified urinary incontinence

2.4

85.9

798

2561

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.7

85.9

1937

8817

RK323

NOMESCO Finland

23.2

85.6

134

S76

ICPC

Skin infection other

2.0

85.5

1213

4713

R50.9

ICD-10 Finland

Fever, unspecified

1.5

85.3

3487

18436

A06AC51

ATC

ispaghula, combinations; systemic

1.9

85.1

1345

5442

K07

ICPC

Swollen ankles/oedema

2.1

85.1

1007

3629

Z00.0

ICD-10 Finland

General medical examination

1.4

85.0

4771

26850

T07

ICPC

Weight gain

3.8

84.8

394

795

N06AA10

ATC

nortriptyline; systemic

2.6

84.4

660

1928

A11

ICPC

Chest pain NOS

1.7

84.4

1757

7803

IEY18

NOMESCO Finland

Psychiatric sleep coaching, individual

184.7

84.3

F32.8

ICD-10 Finland

Other depressive episodes

3.1

84.2

501

1227

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.8

84.1

1601

6911

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

83.9

3625

19384

N06AB08

ATC

fluvoxamine; oral

2.4

83.5

763

2430

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.5

83.2

2831

14359

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.6

83.1

2377

11551

J37.0

ICD-10 Finland

Chronic laryngitis

2.3

83.1

847

2850

SPAT1234

SPAT

Support of social functional capacity

2.0

82.8

1236

4896

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.9

82.5

1377

5683

N06BA07

ATC

modafinil; oral

8.5

82.3

196

176

N07BB01

ATC

disulfiram; oral

2.2

82.0

914

3204

MAX99

NOMESCO Finland

Assistance to normal delivery

0.5

82.0

827

11690

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.8

81.8

1426

5973

K07.60

ICD-10 Finland

Snapping jaw

1.8

81.3

1492

6361

L60.0

ICD-10 Finland

Ingrowing nail

2.0

81.1

1128

4348

A08AB01

ATC

orlistat; oral

5.1

80.8

276

410

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

80.7

1597

6976

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.6

80.5

2370

11600

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

5.3

80.4

269

390

K86

ICPC

Hypertension uncomplicated

1.6

80.4

2472

12231

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.7

80.4

1703

7600

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

80.4

3585

19283

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

79.7

2377

11669

R01AD05

ATC

budesonide; nasal

1.6

79.7

2193

10545

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.6

79.6

2513

12513

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

79.5

3393

18085

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

79.4

1766

7999

U04

ICPC

Incontinence urine

2.0

79.3

1118

4331

K80

ICPC

Cardiac arrhythmia NOS

1.7

79.2

1771

8034

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

79.0

1656

7367

S21

ICPC

Skin texture symptom/complaint

1.5

79.0

3025

15751

SPAT1379

SPAT

Health check-up of pregnant person

0.6

79.0

1014

13427

N30.0

ICD-10 Finland

Acute cystitis

1.4

78.8

3848

21070

R12

ICD-10 Finland

Heartburn

1.7

78.8

1850

8514

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.1

78.5

946

3436

C09DA03

ATC

valsartan and diuretics; oral

2.1

78.4

1019

3821

SPAT1243

SPAT

Psychiatric/psychological examination

2.2

78.3

829

2840

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

78.3

1511

6549

SPAT1283

SPAT

Restricted health certificate

1.4

78.0

5405

31495

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

77.9

6649

40021

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.6

77.7

634

1896

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

77.3

939

3423

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

76.8

1586

7021

SPAT1257

SPAT

Teaching of medicine inhalation technique

2.2

76.6

871

3084

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.5

76.3

677

2121

G04BD07

ATC

tolterodine; oral

1.9

76.2

1247

5108

A99

ICPC

Disease/condition unspecnature/site

1.7

76.1

1942

9147

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.3

76.0

7968

49355

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.6

76.0

1966

9294

C09CA07

ATC

telmisartan; oral

1.8

75.9

1516

6642

N62

ICD-10 Finland

Hypertrophy of breast

1.9

75.7

1271

5254

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.8

75.7

1314

5494

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

75.6

3161

16764

N02AA05

ATC

oxycodone; systemic

1.5

75.5

3095

16344

R06AX13

ATC

loratadine; oral

1.4

75.3

4485

25458

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

75.3

1477

6434

N06AA04

ATC

clomipramine; systemic

2.9

75.2

502

1331

J01FA15

ATC

telithromycin; oral

1.5

75.1

2656

13577

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.6

75.0

2367

11776

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.9

74.9

1232

5057

F51.8

ICD-10 Finland

Other nonorganic sleep disorders

5.4

74.7

243

341

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

74.7

1386

5928

H01

ICPC

Ear pain/earache

1.5

74.6

2897

15118

SPAT1252

SPAT

Overall medication plan or its review

1.7

74.6

1571

6997

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.8

74.6

1387

5937

AN1

Coronary angiography

1.6

74.5

2083

10054

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.7

74.4

1727

7919

SPAT1043

SPAT

Audiometry

1.6

74.4

2247

11060

S97

ICPC

Chronic ulcer skin

1.9

73.6

1108

4401

XA800

NOMESCO Finland

Neuropsychological investigation

2.1

73.6

949

3546

C09BA02

ATC

enalapril and diuretics; systemic

1.7

73.4

1652

7506

R03BC03

ATC

nedocromil; inhalant

1.6

73.3

1917

9087

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

72.9

8684

54650

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

72.7

7637

47265

A28

ICPC

Limited function/disability NOS

1.5

72.6

3194

17113

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.0

72.5

992

3798

U02

ICPC

Urinary frequency/urgency

1.4

72.4

3553

19450

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.2

72.3

809

2842

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

3.2

72.1

422

1023

R55

ICD-10 Finland

Syncope and collapse

1.6

72.0

2368

11896

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.1

71.8

896

3303

J01CA08

ATC

pivmecillinam; oral

1.2

71.7

12996

85963

X58

ICD-10 Finland

Exposure to other specified factors

1.4

71.6

3368

18279

H29

ICPC

Ear symptom/complaint other

1.5

71.5

2427

12281

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.8

71.5

1351

5812

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.0

71.5

1031

4030

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.2

71.4

764

2630

S80.0

ICD-10 Finland

Contusion of knee

1.7

71.3

1744

8116

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.6

71.3

1826

8606

F50.0

ICD-10 Finland

Anorexia nervosa

31.4

71.2

103

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.6

71.2

2078

10135

D07XC01

ATC

betamethasone, combinations; topical

1.5

71.0

2768

14452

N06AX17

ATC

milnacipran; oral

3.4

71.0

379

858

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

70.9

2834

14875

F39

ICD-10 Finland

Unspecified mood [affective] disorder

2.7

70.7

527

1498

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.7

70.2

1646

7566

F31

ICD-10 Finland

Bipolar affective disorder

3.4

70.1

377

859

A10BJ05

ATC

dulaglutide; parenteral

5.0

69.8

244

373

F41.00

ICD-10 Finland

Moderate panic disorder

2.7

69.7

509

1428

M10

ICD-10 Finland

Gout

2.3

69.7

701

2344

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

69.6

3690

20486

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.5

69.4

610

1904

E03

ICD-10 Finland

Other hypothyroidism

1.7

69.4

1613

7396

D01AC02

ATC

miconazole; topical

1.7

69.3

1716

8009

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

5.4

69.2

226

319

A03CA02

ATC

clidinium and psycholeptics; oral

1.7

69.1

1445

6419

MA2HE

NOMESCO Finland

Detailed morfological ultrasound examination of fetus

0.7

69.0

1979

21933

Z34.0

ICD-10 Finland

Supervision of normal first pregnancy

0.6

68.8

1431

16927

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.7

68.5

1550

7049

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.7

68.5

512

1456

I50

ICD-10 Finland

Heart failure

2.4

68.4

629

2008

M54.3

ICD-10 Finland

Sciatica

1.7

68.3

1453

6488

OAA65

SPAT

1.5

67.9

2617

13625

K04.08

ICD-10 Finland

Other specified pulpit

1.6

67.8

1720

8081

J01EA01

ATC

trimethoprim; systemic

1.3

67.8

7289

45172

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.0

67.7

986

3865

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.0

67.6

436

1131

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.0

67.6

897

3390

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.4

67.5

638

2067

S22

ICPC

Nail symptom/complaint

1.8

67.5

1352

5925

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

2.1

67.3

844

3117

C08CA02

ATC

felodipine; oral

1.6

67.1

1860

8947

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

67.1

3183

17292

A10BB12

ATC

glimepiride; oral

1.8

66.9

1310

5700

A10BD07

ATC

metformin and sitagliptin; systemic

2.1

66.5

801

2908

J02AC02

ATC

itraconazole; systemic

1.3

66.5

4817

28181

P20

ICPC

Memory disturbance

1.5

66.5

2419

12430

I50.0

ICD-10 Finland

Congestive heart failure

1.8

66.5

1290

5597

M15

ICD-10 Finland

Polyarthrosis

1.8

66.5

1172

4927

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

66.4

1719

8121

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.2

66.4

721

2499

214

Kela drug reimbursment

Severe and chronic narcolepsy

+∞

66.4

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.0

66.3

290

556

A01AB09

ATC

miconazole; local oral

1.5

66.3

2278

11555

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

3.0

66.1

409

1030

H02

ICPC

Hearing complaint

1.5

65.7

2527

13143

M01AC01

ATC

piroxicam; systemic, rectal

1.4

65.7

3120

16949

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

3.5

65.7

339

748

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.7

65.7

1640

7672

SFA00

NOMESCO Finland

Small filling

1.4

65.6

3267

17909

TFP20

NOMESCO Finland

Cardiodefibrillation

1.8

65.6

1226

5254

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

65.5

1472

6680

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.5

65.5

2767

14684

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.8

65.5

1309

5734

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

3.1

65.4

389

954

SPAT1255

SPAT

Intravenous administration of medicine

1.7

65.4

1459

6607

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

2.3

65.4

634

2081

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.7

65.3

1544

7111

D19

ICPC

Teeth/gum symptom/complaint

1.3

65.3

7075

43852

F51.3

ICD-10 Finland

Sleepwalking [somnambulism]

50.3

65.3

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

1.5

65.1

2408

12415

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.0

64.9

917

3555

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

64.9

1799

8653

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

64.9

1802

8671

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

64.8

6842

42256

SPAT1238

SPAT

Brief therapy

2.4

64.7

577

1815

SXC05

NOMESCO Finland

Other oral or dental procedure

1.7

64.7

1481

6757

H81

ICPC

Excessive ear wax

1.4

64.7

3387

18740

G03DB01

ATC

dydrogesterone; oral

1.4

64.6

4215

24235

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

3.9

64.3

289

568

D02AE01

ATC

carbamide; topical

1.6

64.2

1694

8045

RK250

NOMESCO Finland

7.0

64.1

171

185

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.9

63.7

946

3740

H13

ICPC

Plugged feeling ear

1.4

63.6

3924

22345

WX402

NOMESCO Finland

General anaesthesia

1.4

63.6

4034

23079

MA2JE

NOMESCO Finland

Ultrasound screening of fetal nuchal translucency

0.5

63.5

749

10159

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.6

63.5

1698

8091

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

4.0

63.5

280

541

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

63.4

3553

19900

D07AA02

ATC

hydrocortisone; topical

1.4

63.4

3674

20699

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.0

63.4

835

3148

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

1.8

63.3

1190

5109

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

63.3

1766

8507

M01AB55

ATC

diclofenac, combinations; oral

1.6

63.1

1621

7639

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.5

63.1

2462

12839

C09DA07

ATC

telmisartan and diuretics; oral

2.0

63.1

835

3153

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

62.9

4984

29537

SGC10

NOMESCO Finland

Covering pulpa of tooth

1.5

62.9

2417

12564

C10AA03

ATC

pravastatin; oral

1.7

62.9

1422

6464

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

5.1

62.9

216

324

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.8

62.9

1087

4539

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

3.2

62.7

357

850

SPAT1325

SPAT

Vaccination

1.3

61.9

8695

55589

F51.4

ICD-10 Finland

Sleep terrors [night terrors]

95.2

61.9

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.7

61.9

1326

5933

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

3.6

61.9

306

653

A02BA04

ATC

nizatidine; systemic

1.6

61.7

1784

8672

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

61.7

1709

8216

F32.0

ICD-10 Finland

Mild depressive episode

2.1

61.6

718

2570

F60.5

ICD-10 Finland

Anankastic personality disorder

3.3

61.5

342

800

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

2.1

61.4

774

2865

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.5

61.4

2372

12343

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

61.3

5543

33478

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.5

61.3

2058

10378

J01DA06

ATC

[U] cefuroxime; systemic

1.4

61.2

3885

22220

F33.8

ICD-10 Finland

Other recurrent depressive disorders

3.8

61.1

280

560

C01CA24

ATC

epinephrine; parenteral

1.6

61.1

1719

8298

M77.1

ICD-10 Finland

Lateral epicondylitis

1.6

61.1

1841

9045

K59.0

ICD-10 Finland

Constipation

1.7

60.9

1298

5797

SPAT1360

SPAT

Extensive global examination

1.6

60.9

1779

8671

Z39.2

ICD-10 Finland

Routine postpartum follow-up

0.6

60.6

1449

16664

F54

ICD-10 Finland

Psychological and behavioural factors associated with disorders or diseases classified elsewhere

30.4

60.5

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

60.4

2837

15364

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

60.3

962

3905

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.5

60.3

2280

11808

D01AC03

ATC

econazole; topical

1.7

60.2

1328

5993

AA400

NOMESCO Finland

Electroconvulsive therapy

3.9

59.9

271

536

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

59.9

2121

10823

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.5

59.8

1999

10065

XKC03

NOMESCO Finland

Water cystometry

2.1

59.8

775

2903

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

0.7

59.7

1934

20994

G03DC02

ATC

norethisterone; oral

1.4

59.6

3362

18834

R4110

NOMESCO Finland

Physiotherapy

1.3

59.6

6496

40217

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

59.5

5480

33161

F40.1

ICD-10 Finland

Social phobias

2.3

59.5

623

2122

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

59.4

2810

15234

M77.4

ICD-10 Finland

Metatarsalgia

1.7

59.2

1435

6653

SPAT1359

SPAT

Use of symptom diary

2.3

59.0

617

2100

C07AB12

ATC

nebivolol; oral

2.2

59.0

645

2244

XG405

NOMESCO Finland

Education on PEF monitoring

2.9

58.9

400

1073

3051

Kela drug reimbursment

9.7

58.8

129

101

IEY01

NOMESCO Finland

Psychoeducation, individual

4.0

58.7

253

479

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.7

58.7

1437

6680

Z00.8

ICD-10 Finland

Other general examinations

1.6

58.6

1747

8554

D07CC01

ATC

betamethasone and antibiotics; topical

1.4

58.5

3211

17898

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.8

58.4

1183

5202

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.0

58.3

760

2853

D02

ICPC

Abdominal pain epigastric

1.7

58.3

1462

6842

K05.31

ICD-10 Finland

Periodontitis pronounced

1.5

58.3

1948

9807

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

4.5

58.0

225

385

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.7

57.9

1290

5837

DFF00

NOMESCO Finland

Pure tone audiometry

1.5

57.9

1936

9746

A07AA02

ATC

nystatin; oral

1.6

57.9

1495

7055

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.5

57.8

1956

9876

K08.80

ICD-10 Finland

Toothache NOS

1.5

57.8

2086

10689

C08DA01

ATC

verapamil; systemic

1.9

57.7

946

3878

S01

ICPC

Pain/tenderness of skin

1.8

57.4

1008

4231

SJB60

NOMESCO Finland

External device grinding and adaptation

3.0

57.2

363

932

A10BJ01

ATC

exenatide; parenteral

4.3

57.1

228

402

R03BB01

ATC

ipratropium bromide; inhalant

1.9

57.0

890

3583

H02AB09

ATC

hydrocortisone; systemic

2.3

57.0

590

2000

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.6

56.8

1538

7346

S02.51

ICD-10 Finland

Fracture of tooth, open

1.5

56.6

2397

12706

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.8

56.6

1001

4212

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

56.4

2160

11211

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.2

56.2

593

2028

Z08

ICPC

Social welfare problem

3.0

56.2

358

922

D06

ICPC

Abdominal pain localized other

1.5

56.2

2066

10629

G04CA02

ATC

tamsulosin; oral

1.4

56.2

2707

14724

282

Kela drug reimbursment

Sodium oxybat

+∞

56.1

R28

ICPC

Limited function/disability (R)

3.2

55.9

321

768

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

4.2

55.8

228

411

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

0.7

55.8

1879

20274

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.5

55.6

1810

9051

N03AF01

ATC

carbamazepine; oral, rectal

1.7

55.6

1176

5239

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

55.4

1805

9029

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.4

55.4

529

1724

M01AB08

ATC

etodolac; oral

1.6

55.4

1780

8876

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.2

55.3

621

2187

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.5

55.3

1939

9869

C08DB01

ATC

diltiazem; oral

1.8

55.1

1075

4668

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

1.8

55.1

1108

4859

K05.30

ICD-10 Finland

Periodontitis complex

1.4

54.9

2672

14560

N05AE04

ATC

ziprasidone; systemic

3.9

54.7

245

481

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.0

54.6

712

2673

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.5

54.4

2326

12354

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.2

54.3

588

2037

HMAK

NOMESCO Finland

1.4

54.3

3204

18072

R04.0

ICD-10 Finland

Epistaxis

1.6

54.2

1415

6693

M54.1

ICD-10 Finland

Radiculopathy

1.9

54.2

907

3745

P25

ICPC

Phase of life problem adult

1.7

54.2

1107

4881

R04.2

ICD-10 Finland

Haemoptysis

2.1

53.7

631

2269

IER01

NOMESCO Finland

Psychoeducation, group

4.7

53.5

197

320

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

53.5

2327

12402

SPAT1284

SPAT

Extensive health certificate

2.0

53.4

733

2810

TAB00

NOMESCO Finland

Lumbar puncture

1.8

53.3

1075

4719

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.2

53.3

612

2177

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.6

53.3

1483

7133

-31

ICPC

Medical examin/health eval partial

1.6

53.2

1670

8279

F51.1

ICD-10 Finland

Nonorganic hypersomnia

14.1

53.1

L11

ICPC

Wrist symptom/complaint

1.5

53.0

2049

10652

Z01.7

ICD-10 Finland

Laboratory examination

1.4

53.0

2654

14532

D01AE15

ATC

terbinafine; topical

1.6

53.0

1415

6734

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

52.9

3638

21041

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.0

52.8

722

2765

D07AB08

ATC

desonide; topical

1.4

52.8

2632

14400

F50.1

ICD-10 Finland

Atypical anorexia nervosa

25.4

52.7

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.6

52.6

1376

6511

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

4.1

52.5

220

407

A29

ICPC

General symptom/complaint other

1.4

52.4

2556

13925

N05AF01

ATC

flupentixol; systemic

2.6

52.4

410

1200

ZXA00

NOMESCO Finland

Right side

1.3

52.4

6430

40308

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.8

52.3

1026

4466

M43.1

ICD-10 Finland

Spondylolisthesis

1.8

52.3

926

3897

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.5

52.0

457

1428

K10.3

ICD-10 Finland

Alveolitis of jaws

1.7

52.0

1123

5033

WX725

NOMESCO Finland

Noninvasive ventilation

1.8

52.0

1011

4388

WZA00

NOMESCO Finland

Short statement of of health and health related matters

1.6

52.0

1506

7318

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.6

52.0

1305

6107

K78

ICPC

Atrial fibrillation/flutter

1.6

52.0

1336

6295

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.8

51.8

898

3750

H02.3

ICD-10 Finland

Blepharochalasis

1.6

51.7

1407

6729

A05

ICPC

Feeling ill

1.6

51.4

1545

7577

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.6

51.4

1627

8081

G57.1

ICD-10 Finland

Meralgia paraesthetica

2.7

51.2

368

1026

L04

ICPC

Chest symptom/complaint

1.6

51.0

1356

6444

A10BG03

ATC

pioglitazone; oral

2.4

50.9

466

1488

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.9

50.8

795

3202

WX307

NOMESCO Finland

Obstetric epidural analgesia

0.6

50.7

718

9300

J01

ICD-10 Finland

Acute sinusitis

1.6

50.7

1312

6190

J05AB01

ATC

aciclovir; systemic

1.3

50.7

5592

34567

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.7

50.7

1081

4828

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.5

50.7

1684

8461

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.5

50.6

1678

8424

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.2

50.6

546

1888

K04

ICPC

Palpitations/awareness of heart

1.7

50.6

1224

5670

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

50.5

7705

49497

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

50.4

3341

19202

B01AC04

ATC

clopidogrel; oral

1.4

50.3

2598

14302

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.5

50.3

1658

8313

N02AJ13

ATC

tramadol and paracetamol; systemic

2.3

50.0

488

1608

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.8

49.9

953

4113

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

3.7

49.7

233

477

SGA04

NOMESCO Finland

Very demanding opening and dilatation of root canal of tooth

1.4

49.6

2696

14974

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

1.9

49.6

752

2995

K08.3

ICD-10 Finland

Retained dental root

1.6

49.5

1368

6567

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

2.7

49.5

375

1078

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.6

49.5

393

1162

C07AG02

ATC

carvedilol; oral

1.7

49.5

1102

4986

F41.3

ICD-10 Finland

Other mixed anxiety disorders

2.6

49.4

389

1145

M09AX01

ATC

hyaluronic acid; parenteral

1.7

49.4

1034

4591

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.6

49.3

1479

7250

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

49.3

1854

9575

H60

ICD-10 Finland

Otitis externa

1.7

49.2

1103

5000

QBJ30

NOMESCO Finland

Correction of abdominal apron

3.2

49.1

278

661

M01AB01

ATC

indometacin; systemic, rectal

1.6

49.0

1375

6626

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

3.6

48.8

239

508

G04BD11

ATC

fesoterodine; oral

2.0

48.6

687

2666

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.9

48.4

742

2966

R06AX26

ATC

fexofenadine; oral

1.5

48.3

1806

9316

G03AC03

ATC

levonorgestrel; systemic

1.3

48.2

3549

20726

K03.66

ICD-10 Finland

Tooth plaque

1.6

48.2

1448

7100

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.8

48.2

934

4050

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.1

48.2

586

2139

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.3

48.0

485

1628

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.8

47.7

894

3834

F29

ICPC

Eye symptom/complaint other

1.5

47.7

1937

10167

G04BD09

ATC

trospium; oral

2.1

47.6

613

2290

G01AF05

ATC

econazole; vaginal

1.4

47.6

2448

13460

R06.4

ICD-10 Finland

Hyperventilation

2.3

47.6

458

1499

H25.8

ICD-10 Finland

Other senile cataract

1.5

47.5

2031

10776

M76.6

ICD-10 Finland

Achilles tendinitis

1.7

47.4

992

4404

S04

ICPC

Lump/swelling localized

1.4

47.4

2205

11896

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

1.4

47.4

2346

12808

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

5.9

47.3

143

185

Z37.0

ICD-10 Finland

Single live birth

0.6

47.3

1144

13148

UJD02

NOMESCO Finland

Gastroscopy

1.7

47.2

1060

4807

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.6

47.2

1297

6218

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

47.1

1312

6308

IBA03

NOMESCO Finland

Psychotherapy evaluation

3.4

46.9

248

560

M01AH03

ATC

valdecoxib; oral

1.6

46.9

1415

6943

ZXA05

NOMESCO Finland

Left side

1.3

46.9

5981

37590

G43.3

ICD-10 Finland

Complicated migraine

2.3

46.9

470

1572

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

2.8

46.8

329

905

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.7

46.7

1127

5216

R40.0

ICD-10 Finland

Somnolence

6.2

46.7

135

165

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.7

46.6

951

4191

E000006

ATC

1.5

46.5

1808

9402

A97

ICPC

No disease

1.3

46.5

3554

20866

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

4.7

46.4

169

272

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.8

46.4

885

3818

N05AL01

ATC

sulpiride; systemic

2.6

46.3

376

1125

U07

ICPC

Urine symptom/complaint other

1.6

46.3

1284

6171

E000002

ATC

1.4

46.1

2908

16561

R4120

NOMESCO Finland

Occupational therapy

1.6

46.1

1424

7030

F60.8

ICD-10 Finland

Other specific personality disorders

3.8

46.0

212

428

-50

ICPC

Medication/prescr/renewal

1.7

45.8

961

4268

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.0

45.8

638

2462

H92.0

ICD-10 Finland

Otalgia

1.6

45.8

1290

6225

LCA13

NOMESCO Finland

Curettage of cervix and body of uterus

1.5

45.7

1619

8250

A08AA10

ATC

sibutramine; oral

5.5

45.3

145

202

AA43B

NOMESCO Finland

134.4

45.2

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

45.2

5983

37739

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

2.5

45.1

394

1228

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

2.1

45.1

572

2126

I20.09

ICD-10 Finland

Unstable angina

1.7

45.1

942

4181

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.7

45.0

1085

5021

N03AF02

ATC

oxcarbazepine; oral

1.9

45.0

724

2948

J30.3

ICD-10 Finland

Other allergic rhinitis

1.8

44.8

901

3951

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.0

44.8

649

2543

R31

ICD-10 Finland

Unspecified haematuria

1.5

44.8

1706

8835

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.8

44.7

852

3673

MA5AE

NOMESCO Finland

Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation

0.4

44.7

246

4225

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.7

44.6

1031

4713

R25.1

ICD-10 Finland

Tremor, unspecified

2.0

44.6

603

2300

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.5

44.5

1671

8624

D01AE16

ATC

amorolfine; topical

1.4

44.5

2546

14261

R73.0

ICD-10 Finland

Abnormal glucose tolerance test

2.2

44.4

507

1799

L18

ICPC

Muscle pain

1.8

44.4

892

3912

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.0

44.3

577

2167

104

Kela drug reimbursment

Thyroid insufficiency

1.5

44.2

1872

9908

AA40C

NOMESCO Finland

371.6

44.1

C01BC04

ATC

flecainide; systemic

1.9

44.1

647

2547

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

3.2

44.1

251

600

R49.01

ICD-10 Finland

Functional dysphonia

1.8

44.1

762

3182

F51.5

ICD-10 Finland

Nightmares

19.6

44.1

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.2

44.0

500

1773

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.4

44.0

2069

11181

A10AE05

ATC

insulin detemir; parenteral

1.6

43.9

1140

5385

T78.4

ICD-10 Finland

Allergy, unspecified

1.6

43.9

1194

5710

SPAT1081

SPAT

Cardiorespiratory global assessment

1.6

43.9

1141

5389

L05

ICPC

Flank/axilla symptom/complaint

1.6

43.8

1187

5670

G54.0

ICD-10 Finland

Brachial plexus disorders

1.9

43.7

640

2518

D09

ICPC

Nausea

1.7

43.7

1075

5003

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

4.9

43.7

155

243

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

3.1

43.6

256

626

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

1.7

43.6

900

3980

L29.9

ICD-10 Finland

Pruritus, unspecified

2.0

43.5

568

2136

W19

ICD-10 Finland

Unspecified fall

1.4

43.4

2046

11059

R07.0

ICD-10 Finland

Pain in throat

1.5

43.4

1528

7775

G01AF01

ATC

metronidazole; vaginal

1.4

43.3

2920

16805

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

43.3

2065

11191

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.5

43.0

1618

8353

358

Kela drug reimbursment

liraglutide

5.4

43.0

140

199

R78

ICPC

Acute bronchitis/bronchiolitis

2.1

43.0

527

1930

M54.8

ICD-10 Finland

Other dorsalgia

1.7

43.0

956

4321

R05DA01

ATC

ethylmorphine; oral

1.4

42.9

1932

10350

C03BA11

ATC

indapamide; oral

2.0

42.9

596

2299

H66.9

ICD-10 Finland

Otitis media, unspecified

1.5

42.8

1424

7155

J01MA06

ATC

norfloxacin; oral

1.3

42.8

3447

20381

SCA02

NOMESCO Finland

Analysis and advice of nutrition with regard to dentistry

1.4

42.6

2509

14116

M01AX01

ATC

nabumetone; oral

1.7

42.4

996

4575

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.8

42.4

849

3720

F43.00

ICD-10 Finland

Acute stress reaction mild

1.9

42.3

670

2711

GD1UN

NOMESCO Finland

Lung circulation SPECT

4.3

42.3

169

300

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.7

42.2

882

3914

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.5

42.2

359

1104

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

4.0

42.1

184

355

MA3AE

NOMESCO Finland

Combined first trimester screening

0.4

42.1

245

4125

M35.7

ICD-10 Finland

Hypermobility syndrome

2.3

41.8

412

1368

J01DC02

ATC

cefuroxime; systemic

1.5

41.8

1408

7093

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

2.7

41.7

306

864

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

41.7

997

4601

GD2SN

NOMESCO Finland

Lung ventilation SPECT

4.1

41.7

177

333

P80

ICPC

Personality disorder

4.1

41.6

173

319

J01MA01

ATC

ofloxacin; systemic

1.5

41.5

1767

9358

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.8

41.5

727

3050

S89.9

ICD-10 Finland

Unspecified injury of lower leg

1.8

41.4

806

3501

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

3.9

41.4

184

361

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.7

41.4

987

4554

Z50.1

ICD-10 Finland

Other physical therapy

1.6

41.3

1226

5991

B35.3

ICD-10 Finland

Tinea pedis

1.8

41.3

826

3616

R07

ICPC

Sneezing/nasal congestion

1.5

41.3

1666

8731

M10.0

ICD-10 Finland

Idiopathic gout

2.2

41.2

456

1598

R52.0

ICD-10 Finland

Acute pain

1.8

41.2

727

3057

8811

FHL

Cesarean section

1.5

41.1

1586

8232

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.9

41.1

629

2516

SJB10

NOMESCO Finland

Fitting of loose orthodontic device with user information, demanding

3.7

41.1

193

397

E000003

ATC

1.6

41.0

1075

5089

A08AA02

ATC

fenfluramine; oral (centrally acting antiobesity products)

2.8

41.0

276

741

K29.7

ICD-10 Finland

Gastritis, unspecified

1.8

40.9

750

3194

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.0

40.5

554

2123

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.0

40.4

587

2304

A10BH02

ATC

vildagliptin; oral

2.3

40.2

385

1260

Y6099

ICD-8 Finland

Prenatal care and observation

1.6

40.2

1230

6054

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.6

40.2

1143

5527

C10AC01

ATC

colestyramine; oral

1.9

40.1

611

2441

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

1.9

40.1

669

2759

L30.4

ICD-10 Finland

Erythema intertrigo

2.7

40.0

296

841

IGV01

NOMESCO Finland

Psychiatric network contact

3.3

40.0

220

514

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

39.9

4848

30221

D12

ICPC

Constipation

1.8

39.9

694

2905

C09DB01

ATC

valsartan and amlodipine; oral

2.1

39.9

500

1851

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.1

39.9

483

1761

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.0

39.7

525

1986

A10BX01

ATC

guar gum; systemic

1.8

39.7

772

3350

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.5

39.7

1539

7998

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.3

39.7

381

1249

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.7

39.6

840

3743

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.6

39.6

1002

4696

J01CF05

ATC

flucloxacillin; systemic

1.8

39.6

784

3424

OAB93

SPAT

1.8

39.6

676

2813

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

39.6

803

3533

NOMESCO Finland

Other rehabilitation services

333.4

39.5

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

39.5

1476

7607

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

3.9

39.5

174

339

SPAT1241

SPAT

Extensive assessment of psychosocial situation

2.5

39.4

342

1065

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

39.3

3388

20206

P15

ICPC

Chronic alcohol abuse

2.1

39.2

481

1764

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.7

39.2

829

3693

J35.1

ICD-10 Finland

Hypertrophy of tonsils

2.2

39.2

448

1594

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

39.1

2413

13677

D10

ICPC

Vomiting

1.5

39.1

1511

7844

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.3

39.1

2893

16877

SPAT1266

SPAT

Separate instruction to prepare for procedure

1.9

39.0

631

2574

H60.8

ICD-10 Finland

Other otitis externa

1.9

39.0

619

2508

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.8

38.9

267

725

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.3

38.9

3128

18470

XG460

NOMESCO Finland

Short time oxymetry

2.4

38.9

356

1138

M02AA15

ATC

diclofenac; topical (antiinflammatory prep., non-steroids for topical use)

1.5

38.7

1653

8758

R4140

NOMESCO Finland

Psychotherapy

3.5

38.6

195

427

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.7

38.6

919

4238

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

1.9

38.5

574

2275

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

1.8

38.5

678

2849

G44.0

ICD-10 Finland

Cluster headache syndrome

2.7

38.5

283

801

R75

ICPC

Sinusitis acute/chronic

1.6

38.5

1154

5656

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.0

38.4

527

2021

R09

ICPC

Sinus symptom/complaint

1.4

38.4

2023

11160

KH1AD

NOMESCO Finland

CT of urinary organs

1.9

38.4

598

2407

G47

ICD-10 Finland

Sleep disorders

7.8

38.4

H57.1

ICD-10 Finland

Ocular pain

1.7

38.3

786

3470

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.2

38.2

6790

44091

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.0

38.1

542

2111

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.2

38.1

8283

54837

A12BA01

ATC

potassium chloride; oral

1.7

38.1

841

3797

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.6

38.0

186

397

SFC92

NOMESCO Finland

Other demanding adjuvant procedure of filling therapy

1.5

37.9

1351

6891

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

1.7

37.8

899

4144

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

2.5

37.8

316

964

C10AA04

ATC

fluvastatin; oral

1.5

37.7

1588

8389

S06

ICPC

Rash localized

1.5

37.7

1226

6125

SGB20

NOMESCO Finland

Filling of root of tooth with 2 root channels

1.5

37.7

1449

7514

SPAT1054

SPAT

Examination of peripheral nervous system

2.4

37.7

342

1090

SHA04

NOMESCO Finland

Correction of physiology of bite - very demanding therapy visit

2.4

37.6

330

1032

R73

ICD-10 Finland

Elevated blood glucose level

1.9

37.6

556

2197

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.6

37.5

996

4731

N07CA01

ATC

betahistine; oral

1.5

37.5

1552

8172

SPAT1131

SPAT

Colonoscopy

1.8

37.4

705

3031

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

2.4

37.3

343

1101

R15

ICD-10 Finland

Faecal incontinence

1.9

37.3

624

2579

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

1.8

37.1

704

3034

L09

ICPC

Arm symptom/complaint

1.6

37.1

1012

4841

E66.1

ICD-10 Finland

Drug-induced obesity

5.7

37.1

115

155

R51.81

ICD-10 Finland

Facial pain NOS

1.9

37.0

559

2227

K11.2

ICD-10 Finland

Sialoadenitis

1.8

36.9

722

3139

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

3.4

36.9

193

434

K07.13

ICD-10 Finland

Retrognaty, mandibular

2.3

36.9

359

1183

TKC20

NOMESCO Finland

Catheterisation of bladder

1.5

36.8

1297

6597

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

3.2

36.7

203

477

R03DC01

ATC

zafirlukast; oral

2.2

36.7

396

1373

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

1.9

36.6

603

2480

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.5

36.6

1157

5744

N81.6

ICD-10 Finland

Rectocele

1.4

36.5

1707

9208

NG2AA

NOMESCO Finland

Patella X-ray examination

1.9

36.4

572

2309

M19.9

ICD-10 Finland

Arthrosis, unspecified

1.7

36.4

789

3541

EBA10

NOMESCO Finland

Surgical removal of tooth

1.3

36.4

2989

17692

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.8

36.4

661

2808

C10AB05

ATC

fenofibrate; oral

2.4

36.4

322

1013

K04.00

ICD-10 Finland

Hyperemia of pulp

1.6

36.3

1025

4946

L73.2

ICD-10 Finland

Hidradenitis suppurativa

2.6

36.3

277

802

-45

ICPC

Observ/health educat/advice/diet

1.7

36.3

759

3371

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.5

36.3

1414

7354

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

2.8

36.2

254

700

U05

ICPC

Urination problems other

1.7

36.2

857

3947

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.1

36.1

453

1679

L72.1

ICD-10 Finland

Trichilemmal cyst

1.5

36.0

1317

6755

R06.3

ICD-10 Finland

Periodic breathing

8.1

36.0

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.4

36.0

2177

12293

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.8

36.0

630

2644

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.6

36.0

1002

4820

P02

ICPC

Acute stress reaction

1.5

35.9

1140

5661

N07XX04

ATC

sodium oxybate; oral

302.8

35.8

N89

ICPC

Migraine

1.7

35.8

805

3651

G01AF04

ATC

miconazole; vaginal

1.5

35.8

1407

7331

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.6

35.7

963

4593

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.0

35.7

506

1969

C09DX01

ATC

valsartan, amlodipine and hydrochlorothiazide; oral

2.6

35.7

284

844

F50.4

ICD-10 Finland

Overeating associated with other psychological disturbances

34.6

35.7

TLC02

NOMESCO Finland

Simple extraction of IUD

1.5

35.6

1158

5783

N05BA02

ATC

chlordiazepoxide; systemic

2.1

35.6

422

1525

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3027315) Oxygen [Partial pressure] in Blood

2264

5982

2.54

322.35

4.4

3.8

kpa

8.7

8.6

1.05

2216

5840

(3010421) pH of Blood

2490

6927

2.42

318.34

4.3

3.7

7.4

0.80

2211

5804

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

22290

115915

1.42

317.74

4.2

3.6

—

(3000494) Fungus identified in Specimen by Culture

8162

34413

1.64

314.56

1.5

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

12688

59354

1.51

312.13

1.5

1.4

g/l

2.5

2.4

8.22

7857

36722

(3021901) Oxygen saturation in Capillary blood

1871

4584

2.73

308.30

2.7

2.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

22280

84508

2.17

307.65

4.4

3.9

mg/mmol

9.4

9.1

0.37

14396

53165

(3021601) Nitrite [Presence] in Urine by Test strip

28425

149825

1.47

307.65

5.2

4.6

estimate

0.0

0.03

6363

27522

(3017446) Testosterone [Moles/volume] in Serum or Plasma

6390

21624

2.05

307.65

2.7

2.0

nmol/l

11.9

12.8

13.79

5630

19343

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

45227

234230

2.15

307.65

7.8

7.4

u/l

77.5

77.7

0.25

42710

221075

(3013650) Neutrophils [#/volume] in Blood by Automated count

33922

177758

1.59

307.65

8.4

9.3

e9/l

4.2

4.1

32.02

29910

155617

(3021960) Folate [Moles/volume] in Serum or Plasma

15342

63848

1.78

307.65

1.6

1.5

nmol/l

20.3

0.07

13250

55080

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

30648

144666

1.81

307.65

7.2

6.6

mmol/l

1.2

0.00

25388

122674

(40761511) CBC panel - Blood by Automated count

54968

330280

2.38

307.65

16.6

12.0

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

55688

319713

3.64

307.65

19.9

14.6

mmol/l

4.0

23.00

54642

310966

(3013115) Eosinophils [#/volume] in Blood

31895

158333

1.70

307.65

6.2

e9/l

0.2

28.96

28400

139444

(3022096) Basophils/100 leukocytes in Blood

27993

139169

1.61

307.65

6.2

0.7

0.17

26157

130238

(3024561) Albumin [Mass/volume] in Serum or Plasma

27024

126605

1.74

307.65

4.7

4.9

g/l

36.0

35.6

20.02

25028

117804

(3010813) Leukocytes [#/volume] in Blood

57186

355879

2.89

307.65

25.8

19.0

e9/l

6.9

6.7

137.62

56135

345627

(3002582) Erythrocytes [#/volume] in Urine

18000

89615

1.46

307.65

3.5

3.1

e6/l

64.3

91.5

2.12

14125

68251

(3037522) Nuclear Ab [Titer] in Serum

9808

41880

1.64

307.65

1.4

1.3

titre

488.8

551.4

2.53

1907

8478

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

26375

122125

1.75

307.65

2.6

2.2

nmol/l

3512.9

76.8

0.50

23855

110815

(3026782) Osmolality of Urine

12323

56807

1.53

307.65

2.9

2.7

mosm/kgh2o

549.7

546.2

0.78

10498

48498

(3000492) Spirometry study

7351

29420

1.73

307.65

1.5

1.4

—

(1002224) Polysomnography panel

6953

9201

5.48

307.65

1.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

9524

38735

1.73

307.65

2.8

2.5

22.6

23.1

3.41

8191

33109

(4010399)

6020

20146

2.07

307.65

1.5

1.4

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

36007

173723

1.92

307.65

5.3

4.6

mmol/l

6.8

6.7

38.30

33993

161736

(3012095) Magnesium [Moles/volume] in Serum or Plasma

11141

46470

1.70

307.65

3.2

3.5

mmol/l

0.8

9.41

10370

43462

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

51717

294003

2.26

307.65

15.5

12.0

ml/min/173m2

82.4

83.5

27.22

44442

240846

(42870588) Differential panel, method unspecified - Blood

22169

102742

1.66

307.65

5.8

6.1

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

10242

41730

1.74

307.65

2.7

2.4

g/l

2.4

2.3

39.82

9438

38711

(3019069) Monocytes/100 leukocytes in Blood

28973

144308

1.62

307.65

6.5

6.4

8.4

8.6

9.38

27219

135656

(3007461) Platelets [#/volume] in Blood

57167

355419

2.90

307.65

25.7

19.0

e9/l

252.3

252.9

1.41

56251

346137

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

46397

235957

2.36

307.65

4.7

3.8

pmol/l

14.7

3.46

42613

215993

(3026361) Erythrocytes [#/volume] in Blood

57182

355803

2.89

307.65

25.7

18.9

e12/l

4.6

4.5

177.23

56115

345560

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

15369

72259

1.53

307.65

4.2

4.1

21.9

22.0

0.06

6815

33849

(3003458) Phosphate [Moles/volume] in Serum or Plasma

9328

36633

1.79

307.65

6.0

mmol/l

1.1

1.0

9.95

8698

34250

(3013290) Carbon dioxide [Partial pressure] in Blood

2258

5940

2.55

307.65

4.4

3.7

kpa

5.1

5.0

15.96

2210

5799

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

16285

71492

1.68

307.65

2.4

2.2

mg/l

3.0

2.9

10.52

14030

61244

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

20109

90086

1.70

307.65

4.8

4.7

ug/l

2.8

3.2

0.62

17990

81286

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

52600

283575

3.03

307.65

5.8

4.5

mu/l

2.1

0.12

48952

261527

(3012516) Albumin [Mass/volume] in Urine

21308

80262

2.16

307.65

3.5

3.2

mg/l

344.9

445.6

2.46

13999

50176

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

14444

68092

1.52

307.65

1.3

u/ml

1.3

1.8

4.55

4012

18550

(3015377) Calcium [Moles/volume] in Serum or Plasma

21150

97475

1.66

307.65

2.9

3.5

mmol/l

2.4

1.90

18528

85655

(3022313) Gas panel - Capillary blood

6430

8935

5.17

307.65

3.1

4.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

53439

308155

2.49

307.65

5.3

4.0

mmol/l

1.3

1.5

307.65

49618

286802

(3023368) Bacteria identified in Blood by Culture

16509

77565

1.55

307.65

4.6

4.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

16987

77573

1.61

307.65

1.8

1.6

mmol/l

1.6

1.3

124.57

13713

66244

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

7778

12930

4.39

307.65

3.2

3.9

mmol/l

1.6

1.8

3.51

5959

9326

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

31969

155441

1.76

307.65

5.6

6.3

umol/l

10.8

11.4

13.93

30206

147424

(3028626) Oxygen [Partial pressure] in Capillary blood

2254

5841

2.59

307.65

3.3

3.5

kpa

8.4

8.3

0.58

2082

5444

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

5706

7683

5.28

307.65

3.2

4.7

mmol/l

24.9

24.7

4.82

5350

7065

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

56362

337099

3.27

307.65

12.3

9.7

u/l

30.1

26.3

223.56

54677

326179

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2586

6228

2.80

307.65

3.1

mmol/l

25.1

24.5

9.35

2250

5497

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

15547

64916

1.77

307.65

1.9

1.7

mg/l

0.9

1.2

27.82

11707

49444

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2935

8293

2.39

307.65

2.0

1.6

nmol/l

35.1

42.6

50.28

2848

8110

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

54130

315202

2.57

307.65

17.2

13.0

mg/l

20.4

23.8

111.94

46128

245268

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

19862

87079

1.75

307.65

2.3

2.1

u/l

187.4

213.5

4.13

18610

81893

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

8073

13641

4.34

307.65

3.2

4.0

kpa

5.2

5.1

36.88

7506

12599

(3009261) Glucose [Presence] in Urine by Test strip

28660

151455

1.47

307.65

4.0

3.5

estimate

0.0

2.57

5989

26912

(3015736) pH of Urine

22517

115787

1.44

307.65

3.6

3.2

5.8

5.7

0.15

(3036481) Cortisol [Moles/volume] in Serum or Plasma

7990

25470

2.22

307.65

2.2

2.3

nmol/l

345.6

381.2

43.11

7325

23599

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

52548

280644

3.12

307.65

7.5

5.1

mmol/mol

41.0

39.1

307.65

49266

261004

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

54443

315511

2.75

307.65

5.9

4.5

mmol/l

2.7

2.8

104.30

50616

293078

(3018010) Neutrophils/100 leukocytes in Blood

29132

146695

1.60

307.65

6.1

6.0

57.3

57.1

2.46

27295

137797

(3005322) IgE [Units/volume] in Serum or Plasma

5273

18626

1.94

307.65

1.4

1.3

u/ml

240.5

247.4

0.11

4911

17232

(3019225) pH of Specimen

6994

27120

1.78

307.65

4.5

4.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

24814

107686

1.88

307.65

4.2

3.2

ng/l

53.3

65.4

0.72

16838

68991

(3044889) 12 lead EKG panel

40053

211872

1.75

307.65

4.3

3.5

—

(3013512) EKG study

19565

80120

1.90

307.65

4.4

3.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

28139

130683

1.79

307.65

6.5

5.9

mmol/l

1.2

0.26

25529

118740

(3035350) Ketones [Presence] in Urine by Test strip

28427

149357

1.48

307.65

4.0

3.4

estimate

0.0

0.36

6169

26856

(1616796) Gas panel - Central venous blood

2290

5769

2.67

307.65

3.7

3.5

—

(3022948) Iron [Moles/volume] in Serum or Plasma

11089

45279

1.75

307.65

2.7

2.5

umol/l

13.5

13.7

0.27

10243

42129

(3020564) Creatinine [Moles/volume] in Serum or Plasma

56160

335783

3.11

307.65

19.8

14.8

umol/l

79.8

76.1

94.42

56146

335614

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

14914

58788

1.89

307.65

1.8

1.6

pmol/l

34086912.1

37671223.5

0.28

12348

49184

(40768797) Stomach Pathology biopsy report

10187

39813

1.82

307.65

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

8920

34017

1.85

307.65

5.1

4.1

30.4

32.6

65.88

6999

22948

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

53560

298698

2.95

307.65

5.7

4.1

mmol/l

6.1

5.8

307.65

49287

275140

(3019198) Lymphocytes [#/volume] in Blood

31386

157743

1.65

307.65

6.0

e9/l

2.0

1.9

8.73

28048

139321

(3009343) pH of Capillary blood

8025

13411

4.38

307.65

3.2

4.0

7.4

5.05

837

2014

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

19812

74603

2.12

307.65

3.3

2.8

ng/l

1083.1

1378.9

16.48

16283

63965

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

26488

116013

1.90

307.65

2.2

1.9

pmol/l

98.9

95.7

19.77

14452

60654

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

21684

100660

1.65

307.65

3.2

u/l

32.3

33.8

2.22

20414

95717

(3031040) Bacteria [#/volume] in Urine by Automated count

36807

198752

1.57

307.65

5.0

4.1

e6/l

865.3

1366.7

1.24

604

2649

(3000963) Hemoglobin [Mass/volume] in Blood

57184

355924

2.88

307.65

25.9

19.0

g/l

137.7

135.9

149.95

56649

351152

(3006315) Basophils [#/volume] in Blood

30818

153465

1.66

307.65

6.0

e9/l

0.0

17.35

27022

133207

(3018418) pH of Serum or Plasma

18174

86105

1.55

307.65

4.3

4.1

7.4

1.56

4168

15703

(3018095) Leukocytes [#/volume] in Urine

20717

105557

1.44

307.65

4.0

3.6

e6/l

80.9

94.4

1.21

15181

73842

(3002030) Lymphocytes/100 leukocytes in Blood

29606

148805

1.61

307.65

6.3

6.2

28.1

28.2

1.09

27657

139187

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

53751

310422

2.56

307.65

5.4

4.1

mmol/l

4.6

4.7

241.87

50213

290015

(3021589) Normoblasts [#/volume] in Blood

26180

136208

1.47

307.65

10.8

9.2

e9/l

0.0

2.35

21749

111799

(3001122) Ferritin [Mass/volume] in Serum or Plasma

27808

132225

1.72

307.65

3.3

2.8

ug/l

127.8

124.4

1.18

25680

123406

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

52162

297239

2.32

307.65

4.8

3.6

mmol/l

1.5

1.3

307.65

48111

275229

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

11323

49420

1.62

307.65

1.3

u/ml

8.7

12.1

4.95

4379

19512

(3012501) Base excess in Blood by calculation

2257

5939

2.55

307.65

4.4

3.7

mmol/l

2.5

0.09

1612

3942

(3024731) MCV [Entitic volume]

57181

355766

2.89

307.65

25.6

18.9

90.8

2.54

56640

350960

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

8237

32856

1.75

307.65

1.6

1.7

—

(3013707) Erythrocyte sedimentation rate by Westergren method

44064

226670

2.09

307.65

4.7

3.9

mm/h

12.4

11.5

36.76

41054

210662

(3037467) Urinalysis macro (dipstick) panel - Urine

39428

209796

1.70

307.65

4.8

4.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

10345

45636

1.59

307.65

2.0

1.8

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

2272

5622

2.71

307.65

2.2

1.8

pmol/l

190.0

202.8

6.42

2148

5346

(3032080) INR in Blood by Coagulation assay

25214

116185

1.74

307.65

9.9

8.2

inr

1.2

0.37

8105

33260

(3000850) Epithelial cells [#/volume] in Urine

13168

61493

1.52

307.65

2.8

2.5

e6/l

5.4

5.6

0.77

11476

53766

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

11885

52642

1.60

307.65

1.3

iu/ml

33.9

34.9

0.09

3423

16780

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

9699

38516

1.78

307.65

2.0

1.7

1.5

1.4

2.05

8485

34253

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

20869

93607

1.71

307.65

2.7

2.5

u/l

55.0

58.8

9.39

19155

86660

(3026493) Urate [Moles/volume] in Serum or Plasma

18700

76621

1.88

307.65

2.8

2.5

umol/l

3593.1

4234.1

1.41

16159

67192

(3001604) Monocytes [#/volume] in Blood

30687

152758

1.66

307.65

6.0

e9/l

0.6

24.09

26910

132619

(3019309) Folate [Moles/volume] in Red Blood Cells

12763

49890

1.86

307.65

1.9

1.7

nmol/l

1171.9

1160.6

0.66

9786

37997

(3006504) Eosinophils/100 leukocytes in Blood

28826

143512

1.62

307.65

6.2

6.1

2.9

2.8

7.24

26926

134244

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

40631

212205

1.82

307.65

3.8

2.9

u/l

53.0

46.2

40.77

37947

199625

(3019550) Sodium [Moles/volume] in Serum or Plasma

55585

318681

3.59

307.65

19.8

14.5

mmol/l

139.8

139.6

37.39

54604

310564

(3009508) Creatinine [Moles/volume] in Urine

22993

87711

2.18

307.65

3.5

3.2

mmol/l

8.2

7.8

1.65

19010

74549

(3035941) MCH [Entitic mass]

57176

355722

2.89

307.65

25.6

18.9

30.2

30.3

5.00

56638

350926

(3029937) Albumin [Presence] in Urine by Test strip

16158

79575

1.46

306.77

4.4

3.8

estimate

0.0

0.59

6081

26488

(40760892) CBC W Ordered Manual Differential panel - Blood

14323

68954

1.48

305.14

4.5

4.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

8187

34915

1.62

300.25

1.9

1.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

11272

51824

1.53

298.80

3.0

2.9

ug/l

0.7

0.8

21.32

7191

33230

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

6939

28477

1.68

295.05

3.7

3.2

—

(40761536) Microorganisms panel - Urine sediment

6156

24683

1.71

284.48

4.4

3.7

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

5788

22839

1.73

283.14

4.0

3.8

mmol/l

1.2

7.42

5019

20046

(3030467) Casts [#/volume] in Urine by Automated count

16410

82025

1.43

282.80

3.4

3.1

e6/l

0.4

0.43

12540

61229

(3022145) Colonoscopy Study observation

7813

33524

1.61

277.53

1.3

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

16256

81750

1.42

267.66

3.7

3.1

—

(3019060) Gas panel - Arterial blood

4696

17899

1.78

257.49

4.7

5.0

—

(3048689) Calprotectin [Mass/mass] in Stool

8529

37994

1.55

256.22

2.2

2.4

ug/g

125.5

136.2

1.94

6615

30124

(36304419) Bacteria [Presence] in Urine

15924

80278

1.41

256.14

3.3

3.0

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

10896

51778

1.46

238.43

2.7

3.1

mmol/l

2.4

4.73

9461

45339

(3022217) INR in Platelet poor plasma by Coagulation assay

8102

36246

1.54

236.97

26.2

22.3

inr

1.4

1.3

0.97

1290

5121

(3042936) Bacteria identified in Isolate by Culture

9098

41851

1.50

233.33

2.2

2.0

—

(1761868) Lipid panel - Serum or Plasma

21509

115267

1.35

232.19

3.3

2.6

—

(40767503) Oxygen content in Capillary blood by calculation

1963

5677

2.31

229.25

2.8

2.4

17.1

16.3

9.75

1100

2842

(40768804) Tissue Pathology biopsy report

23148

125688

1.34

227.66

2.1

—

(3003396) Base excess in Arterial blood by calculation

7292

32193

1.55

225.31

7.4

mmol/l

1.3

1.0

13.99

5909

25204

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

7279

32197

1.55

222.80

7.4

kpa

5.2

5.1

38.52

6970

30708

(3027801) Oxygen [Partial pressure] in Arterial blood

7273

32179

1.55

222.31

7.4

kpa

11.3

12.8

115.27

6957

30688

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

5102

20704

1.67

222.29

4.1

3.9

ng/l

94.6

89.5

2.89

4345

18071

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

4726

18819

1.70

220.79

3.1

3.4

pmol/l

4.5

1.04

4173

16873

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

25971

143938

1.33

218.90

4.1

3.9

—

(3020779) Urea [Moles/volume] in Serum or Plasma

5918

25134

1.60

215.06

8.2

7.5

mmol/l

10.1

9.5

8.63

5611

23937

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

4367

17176

1.72

212.98

7.1

7.4

mmol/l

25.1

24.7

11.39

4318

17032

(3021440) Promyelocytes/100 leukocytes in Blood

5622

23691

1.61

210.68

3.9

4.3

0.1

1.75

1524

6381

(3002179) Metamyelocytes/100 leukocytes in Blood

5408

22609

1.62

209.17

3.7

4.1

0.6

0.7

1.10

1214

4967

(3005719) IgG [Mass/volume] in Serum or Plasma

5383

22493

1.63

208.59

2.5

2.7

g/l

10.5

10.6

0.73

4842

20691

(3017181) Myelocytes/100 leukocytes in Blood

5850

24967

1.59

207.87

3.9

4.2

0.9

1.0

1.90

1607

6935

(3026008) Bacteria identified in Urine by Culture

16459

85989

1.35

202.37

3.3

2.9

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

11441

56371

1.41

200.92

4.1

3.5

ng/l

446.6

517.4

0.32

8326

42118

(3028707) Methadone [Presence] in Urine by Screen method

1735

5059

2.29

198.54

2.7

3.1

—

(3025159) Blasts/100 leukocytes in Blood

5313

22387

1.61

198.47

3.9

4.3

0.2

0.17

1319

5384

(3009214) Lutropin [Units/volume] in Serum or Plasma

2525

8551

1.98

197.48

1.4

u/l

8.7

10.7

8.67

2042

6998

(3016502) Oxygen saturation in Arterial blood

6503

28827

1.54

195.07

7.8

94.9

95.9

24.55

6305

27706

(3044640) Blood type and Crossmatch panel - Blood

17927

95629

1.33

188.43

2.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

4471

18283

1.65

187.62

2.1

2.4

—

(4146454)

1079

2589

2.76

184.18

2.7

2.8

—

(3028026) IgM [Mass/volume] in Serum or Plasma

4267

17396

1.65

180.88

1.8

1.9

g/l

1.2

1.3

5.73

3867

15943

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

1156

2908

2.64

180.49

1.3

nmol/l

32.8

27.0

—

(3020630) Protein [Mass/volume] in Serum or Plasma

5255

22669

1.57

176.70

2.2

2.6

g/l

67.0

66.5

5.32

4768

20718

(3014576) Chloride [Moles/volume] in Serum or Plasma

7713

36107

1.46

176.21

7.2

mmol/l

104.4

104.5

1.40

7522

35344

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

3251

12428

1.76

173.94

2.2

2.0

u/l

39.3

39.6

0.40

2906

11094

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

36117

212829

1.29

173.33

3.2

3.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1981

6442

2.05

172.80

2.3

2.4

ug/min

147.7

102.3

2.64

1181

3853

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

3065

11548

1.78

172.23

2.1

1.9

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

5236

22795

1.55

168.71

3.1

2.8

ng/l

159.2

201.3

10.83

4678

20765

(3033658) Prothrombin time (PT) actual/Normal

14743

77616

1.33

164.76

4.0

91.4

91.0

1.19

14314

75693

(3027945) Reticulocytes/100 erythrocytes in Blood

6784

31367

1.47

164.13

2.5

2.6

1.8

1.7

10.61

5951

27929

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

4831

20772

1.57

164.10

2.4

2.3

au/ml

22.6

24.1

0.29

213

1339

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

6008

27120

1.50

163.57

2.2

2.3

g/l

0.2

12.44

5568

25270

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1724

5471

2.10

160.20

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1898

6249

2.02

159.98

2.3

2.1

g/l

134.7

129.6

12.50

1400

4539

(3012544) pH of Venous blood

5974

27065

1.50

159.54

4.5

3.9

7.4

0.30

127

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2796

10527

1.78

157.13

2.0

1.8

—

(3002032) Base excess in Venous blood by calculation

5768

26057

1.50

155.95

4.6

3.9

mmol/l

2.1

1.8

7.92

4827

21233

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

4440

18966

1.58

154.69

1.3

au/ml

45.9

50.1

0.46

154

818

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

892

2135

2.76

152.92

2.0

2.1

nmol/l

18.7

18.4

0.37

843

2017

(3021447) Carbon dioxide [Partial pressure] in Venous blood

5763

26157

1.49

152.06

4.6

3.9

kpa

5.9

5.8

19.17

5603

25372

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

13743

72438

1.32

149.43

2.4

2.3

—

(3028271) Lactate [Moles/volume] in Capillary blood

1419

4294

2.19

148.43

2.2

1.8

mmol/l

1.7

0.12

1396

4185

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

5251

23508

1.51

147.76

2.6

2.2

ug/l

6.1

7.7

6.97

4512

20629

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1597

5087

2.09

146.86

3.1

3.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

4589

20047

1.54

144.45

1.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

6673

31537

1.44

142.36

1.8

1.7

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

3154

12643

1.67

141.40

1.5

u/ml

14.0

14.5

0.07

370

(3023520) Reticulocytes [#/volume] in Blood

5141

23122

1.50

141.15

2.6

2.7

e9/l

73.8

68.9

16.66

3976

17316

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

4742

21021

1.52

139.34

1.2

iu/ml

122.1

147.4

4.34

1715

8029

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3542

14743

1.61

136.84

9.0

9.8

mmol/l

24.7

24.2

13.28

3286

13804

(3021387) Prolactin [Units/volume] in Serum or Plasma

2726

10608

1.72

136.18

1.8

1.6

mu/l

319.7

309.1

0.50

2419

9634

(3025941) Bacteria identified in Stool by Culture

4098

17695

1.56

135.47

1.3

1.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

718

1636

2.90

134.44

3.6

3.1

mu/l

35.8

24.3

8.10

678

1531

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4697

20947

1.51

133.91

1.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2558

9843

1.73

132.92

1.7

1.6

titre

261.7

285.9

0.15

100

414

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1072

14808

0.46

132.49

1.4

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

6631

31730

1.42

131.26

1.9

1.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

7163

34744

1.40

131.18

2.4

2.8

umol/l

7.3

8.6

6.51

6047

30257

(4094501)

2103

7695

1.82

129.38

1.1

—

(3011985) Renin [Units/volume] in Plasma

1241

3761

2.19

129.26

1.5

mu/l

69.7

63.3

0.45

1100

3375

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1627

5473

1.97

128.96

1.2

titre

94.2

145.4

0.70

112

(3017732) Neutrophils [#/volume] in Blood

4685

21046

1.50

128.75

2.8

e9/l

4.2

4.1

1.21

3647

16485

(3022806) Fractional oxyhemoglobin in Capillary blood

1166

3465

2.23

127.31

2.1

1.7

89.7

89.9

0.34

1152

3407

(3014111) Lactate [Moles/volume] in Serum or Plasma

5459

25352

1.45

126.82

7.4

7.1

mmol/l

1.4

1.3

0.38

5230

24483

(3018677) aPTT in Platelet poor plasma by Coagulation assay

8936

45203

1.35

125.63

2.1

30.0

29.7

4.38

8653

43904

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2948

12004

1.64

124.00

1.3

1.2

u/ml

0.5

0.9

1.72

272

1036

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

685

1595

2.84

123.47

12.1

12.0

mmol/l

0.6

1.12

633

1468

(3002173) Hemoglobin [Mass/volume] in Arterial blood

5721

26990

1.43

121.88

8.5

8.2

g/l

125.8

121.0

50.85

5572

25966

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

7284

35874

1.38

120.90

7.4

6.6

—

(3024354) Oxygen [Partial pressure] in Venous blood

4691

21373

1.48

119.82

3.8

3.2

kpa

4.8

4.6

3.70

4539

20643

(3019150) Specific gravity of Urine by Refractometry

12322

65593

1.29

119.73

4.2

3.8

kg/l

1.0

0.34

1733

9907

(3011288) Drugs identified in Urine by Screen method

2231

8507

1.75

119.45

3.3

3.1

—

(40758558) Short blood count panel - Blood

14338

77974

1.27

117.05

6.3

7.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3718

16275

1.53

114.86

1.8

1.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2750

11224

1.64

114.39

1.8

1.6

mg/l

4.4

3.2

4.63

2276

7532

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

1138

3509

2.15

113.55

1.4

pmol/l

306.5

300.5

0.14

897

2709

(3009542) Hematocrit [Volume Fraction] of Blood

47556

295385

1.29

112.84

17.3

14.0

40.6

40.0

37.23

33234

222161

(3000991) Gas panel - Venous blood

5152

24186

1.43

112.18

9.0

8.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

2079

7927

1.74

111.22

2.3

2.0

mg/l

10.6

11.0

1.04

1935

7415

(3002385) Erythrocyte distribution width [Ratio]

43293

266158

1.25

109.64

19.9

15.9

13.7

13.6

31.68

42488

260744

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1224

3963

2.05

107.66

1.3

nmol/l

1.7

1.2

0.26

1183

3816

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2349

9363

1.67

106.94

2.6

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2137

8303

1.71

106.90

1.4

ug/g

290.8

271.6

2.82

1177

4871

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1217

3957

2.04

105.83

1.3

nmol/l

0.3

0.2

0.11

266

(3003129) Base excess in Capillary blood by calculation

331

527

4.13

105.28

1.5

1.8

mmol/l

0.6

0.5

0.22

319

486

(3020891) Body temperature

2648

10974

1.61

103.37

5.1

4.9

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

3070

13213

1.55

101.99

3.9

3.4

mmol/l

25.5

25.2

5.16

2980

12797

(1001926) Buprenorphine [Presence] in Urine by Screen method

2451

10005

1.63

101.66

2.4

2.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2617

10865

1.61

101.37

2.1

2.0

ug/l

1.8

2.3

1.05

2288

9648

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

6675

33265

1.36

101.35

3.6

4.4

u/l

235.7

244.6

5.90

6264

31561

(3009466) Valproate [Moles/volume] in Serum or Plasma

1262

4231

1.98

100.86

5.6

5.0

umol/l

368.3

368.5

0.01

1104

3684

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3892

17669

1.47

100.45

7.7

7.1

mmol/l

25.0

24.5

13.97

3689

16403

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1565

5682

1.83

98.46

1.9

2.1

nmol/l

1.0

0.8

20.30

1290

4792

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

9078

47471

1.30

98.25

3.1

2.8

e6/l

3.0

2.8

0.49

4971

25474

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1107

3582

2.04

97.51

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

9664

51058

1.29

96.45

2.9

2.7

e6/l

1.0

1.2

1.82

5558

28858

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

11082

59605

1.27

95.72

1.6

1.5

—

(3023419) Bacteria identified in Sputum by Culture

1033

3286

2.08

95.19

2.7

2.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

1035

3297

2.08

95.03

2.1

2.0

mg/l

24.6

27.2

0.73

305

852

(3050129) First trimester maternal screen panel - Serum or Plasma

680

9840

0.45

94.83

1.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2291

9384

1.62

93.61

1.6

1.7

g/l

1.2

34.44

2183

8926

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2229

9108

1.63

91.94

1.6

1.7

g/l

0.2

13.36

2122

8625

(3037121) Protein [Mass/volume] in Urine

2357

9770

1.61

91.74

3.0

3.2

g/l

0.3

0.50

982

4481

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3358

15067

1.49

91.59

2.5

2.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

3699

16925

1.46

91.42

3.9

3.3

g/l

132.9

128.8

22.48

3613

16523

(36660697) Celiac disease serology panel - Serum

5069

24566

1.39

90.95

1.2

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

259

388

4.39

88.80

2.7

2.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3379

15340

1.47

86.78

2.9

2.7

e6/l

0.3

0.09

3293

14902

(3042631) Mycobacterium sp identified in Specimen

1077

3601

1.98

86.72

2.7

2.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

1062

3543

1.98

86.05

1.5

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1994

8088

1.64

84.60

1.5

iu/ml

10.8

14.8

0.80

192

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

713

2045

2.30

84.59

1.3

u/ml

0.6

1.3

2.12

304

936

(3034770) Mitochondria Ab [Titer] in Serum

2047

8369

1.62

84.15

1.2

titre

1031.5

919.4

0.28

243

(3014007) Fractional oxyhemoglobin in Arterial blood

3839

17985

1.43

83.39

9.5

9.4

93.2

94.1

14.08

3820

17927

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3646

16924

1.44

83.28

1.6

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1030

3442

1.98

83.07

1.7

1.6

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2236

9394

1.58

82.14

1.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3478

16086

1.44

80.91

1.1

1.0

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

401

877

3.01

80.73

2.3

2.4

ug/l

1.0

1.2

0.58

363

839

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2911

13015

1.49

80.52

3.5

2.9

1.4

1.3

4.74

2901

12941

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1192

4234

1.86

80.30

1.3

u/l

26.2

36.0

2.60

1039

3699

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2324

9918

1.56

79.75

2.2

2.4

ug/l

389.1

566.0

2.37

2174

9284

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3803

17929

1.42

79.63

9.5

9.4

0.7

1.48

3782

17824

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3808

17959

1.42

79.57

9.5

9.3

1.4

4.04

3783

17844

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2766

12277

1.50

79.23

4.4

3.8

50.5

48.1

5.38

2734

12139

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2852

12751

1.49

78.86

3.4

2.9

0.7

1.22

2749

12217

(3027923) C peptide [Moles/volume] in Serum or Plasma

544

1422

2.52

78.82

1.6

nmol/l

1.4

1.2

5.58

406

1151

(3016879) Cocaine [Presence] in Urine

2763

12280

1.50

78.63

2.3

2.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

933

3071

2.01

78.49

14.6

5.9

mmol/l

7.5

7.3

1.27

774

2511

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1926

7891

1.62

78.45

3.1

3.7

mg/l

1.6

1.5

9.39

1757

7312

(3012565) Volume of 24 hour Urine

521

1338

2.57

78.23

1.9

2.2

1981.6

1985.0

0.02

459

1204

(3049717) Cytology report of Urine Cyto stain

2422

10482

1.54

78.05

2.5

2.7

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

12664

70516

1.23

77.48

3.9

3.5

—

(40768443) Skin Pathology biopsy report

2899

13054

1.48

77.34

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2587

11379

1.51

77.34

1.6

1.7

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1858

7580

1.63

76.97

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

586

8276

0.46

76.33

1.4

1.5

—

(3018405) Lactate [Moles/volume] in Arterial blood

2260

9691

1.55

75.89

4.4

4.2

mmol/l

1.4

0.24

2227

9511

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1834

7486

1.62

75.81

1.3

mg/l

530.5

544.6

0.16

1744

7148

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

762

2360

2.13

75.26

1.4

1.3

pmol/l

184.1

74.0

0.74

334

636

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

537

7778

0.45

74.92

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

540

7797

0.45

74.70

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

540

7791

0.45

74.55

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

537

7747

0.45

74.11

1.3

1.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

2006

8430

1.58

73.51

1.3

u/ml

34.1

37.4

0.17

541

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

2011

8460

1.58

73.36

2.8

3.4

mg/l

38.2

43.8

1.14

1501

6972

(3034860) Kappa light chains.free [Mass/volume] in Serum

2013

8474

1.58

73.23

2.8

3.4

mg/l

51.4

65.9

0.89

1504

6973

(3007566) Smooth muscle Ab [Titer] in Serum

2024

8550

1.57

72.53

1.2

1.3

titre

108.5

125.8

0.42

191

774

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1958

8211

1.58

72.39

2.7

3.4

ratio

2.7

4.6

0.78

135

677

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

484

1250

2.55

71.91

1.6

nmol/l

14.0

5.6

0.35

398

1052

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1666

6745

1.64

71.11

1.7

1.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

1529

6060

1.67

70.84

2.7

2.8

umol/l

33.2

34.2

0.76

1304

5134

(3045424) Erythrocytes [Presence] in Urine

1297

4912

1.75

70.83

1.5

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

2890

13227

1.45

70.81

2.3

2.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2983

13760

1.44

70.12

5.1

4.3

mmol/l

24.4

24.1

6.28

2653

12390

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

502

7254

0.45

69.57

1.4

1.5

—

(40761535) Cells panel - Urine sediment

4769

23837

1.34

69.30

3.7

3.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2012

8578

1.56

69.23

1.8

1.7

—

(3028300) Cannabinoids [Presence] in Urine

2900

13348

1.45

68.94

2.3

2.1

—

(3004616) Nuclear Ab [Presence] in Serum

1004

3545

1.87

68.92

1.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1624

6595

1.63

68.47

1.3

mmol/l

3.8

3.7

1.97

1525

6201

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1263

4795

1.74

68.39

1.8

1.7

—

(3027008) Opiates [Presence] in Urine

2889

13316

1.44

68.15

2.3

2.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

4813

24148

1.33

68.11

2.6

2.7

ml/min/173m2

66.7

67.3

0.39

2104

9260

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1015

3641

1.84

66.33

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1035

3739

1.83

66.14

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1006

3604

1.84

66.02

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1015

3650

1.84

65.82

1.4

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

479

1286

2.45

65.77

1.1

u/ml

5.9

10.3

2.34

216

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2361

10538

1.49

65.61

1.9

2.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1004

3602

1.84

65.59

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2363

10551

1.49

65.54

1.9

2.3

g/l

7.4

7.3

0.57

1745

7919

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2356

10523

1.49

65.24

1.9

2.3

g/l

3.9

3.8

0.62

1653

7561

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1842

7806

1.56

65.05

1.3

u/ml

6.7

8.4

0.58

246

1266

(3020961) Endomysium IgA Ab [Titer] in Serum

3116

14688

1.41

64.90

1.1

titre

183.6

210.2

0.18

388

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1001

3600

1.84

64.90

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

5518

28416

1.30

64.62

2.5

u/l

41.4

45.1

0.27

4659

24432

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

547

1579

2.28

64.07

1.1

nmol/l

4.4

5.4

0.24

113

298

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1554

6369

1.62

63.14

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

1257

4876

1.70

63.06

1.4

1.6

g/l

0.8

0.04

902

3716

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2752

12751

1.43

63.02

1.7

g/l

1.6

1.5

2.26

2359

10904

(3017143) Hepatitis C virus Ab [Presence] in Serum

7111

37950

1.26

62.43

1.7

1.6

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1808

7703

1.56

62.35

1.3

u/ml

6.3

5.9

0.06

176

817

(40760888) Immunoglobulin light chains.free panel - Serum

1544

6338

1.61

62.33

2.8

3.5

—

(4015189)

296

631

3.08

62.31

2.1

2.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1586

6555

1.60

62.26

1.7

1.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

899

3167

1.87

62.18

1.1

1.0

—

(3027944) Amphetamines [Presence] in Urine

2815

13138

1.42

61.93

2.3

2.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

507

1440

2.32

61.64

1.6

1.9

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2224

9937

1.48

61.43

1.9

2.3

g/l

3.0

3.1

3.47

1696

7757

(3028192) IgG subclass 2 [Mass/volume] in Serum

867

3038

1.88

60.95

1.3

1.4

g/l

2.9

3.0

0.41

570

2134

(3047352) Trisomy 18 risk [Likelihood] in Fetus

437

6328

0.45

60.90

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

455

6491

0.46

60.89

1.4

1.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1593

6629

1.59

60.78

1.4

e6/l

18.1

33.4

2.37

1242

5115

(3024139) IgG subclass 3 [Mass/volume] in Serum

866

3037

1.88

60.73

1.3

1.4

g/l

0.4

0.39

572

2139

(3027135) IgG subclass 1 [Mass/volume] in Serum

866

3042

1.88

60.43

1.3

1.4

g/l

6.5

6.8

1.96

564

2145

(4062490)

867

3049

1.88

60.29

1.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

232

431

3.54

60.29

1.6

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1592

6637

1.59

60.28

1.4

1.5

e6/l

1375.5

2350.9

0.64

1320

5362

(3005033) Fetal Nuchal fold Thickness US

439

6319

0.45

60.20

1.4

—

(3021788) Differential panel - Synovial fluid

1311

5212

1.66

60.03

1.5

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1509

6220

1.61

59.89

1.2

u/ml

7.2

15.4

0.97

(3044290) Cell count panel - Cerebral spinal fluid

1502

6222

1.60

58.40

1.3

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1181

4601

1.70

58.33

1.4

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

940

3429

1.81

58.26

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1178

4614

1.69

57.05

1.1

iu/ml

38.5

3187.0

0.80

269

1008

(3043409) Potassium [Moles/volume] in Arterial blood

1912

8408

1.51

57.01

4.8

4.5

mmol/l

3.9

0.31

1782

7917

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1814

7897

1.52

56.72

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1982

8794

1.49

56.61

1.4

1.3

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

729

2471

1.94

56.58

1.3

nmol/l

1.7

1.3

10.54

671

2226

(3003327) Ova and parasites identified in Stool by Light microscopy

2307

10559

1.45

56.31

1.7

—

(3045414) Leukocytes [Presence] in Urine

2807

13346

1.40

55.44

1.8

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

489

6574

0.48

55.32

1.7

1.8

—

(3020876) Protein [Mass/time] in 24 hour Urine

676

2253

1.98

55.06

1.9

2.0

g/24h

1.0

0.01

123

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

969

3629

1.76

55.04

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1619

6930

1.55

54.67

1.6

e6/l

12976.0

13194.4

0.06

1193

5035

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1844

8125

1.50

54.46

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2073

9374

1.47

53.85

3.3

3.1

u/ml

0.4

0.3

1.18

1218

5281

(3002256) Pathology report gross observation

7395

40258

1.23

53.59

1.3

—

(3044927) Protein electrophoresis panel - Urine

729

2518

1.91

53.57

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2160

9869

1.45

53.17

1.9

2.3

g/l

10.1

10.3

1.05

1807

8262

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

365

5366

0.44

52.98

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

947

3564

1.75

52.91

1.6

56.4

56.6

0.05

572

2310

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1229

4971

1.63

52.65

1.5

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

426

1211

2.31

51.79

2.0

1.9

umol/l

128.4

132.0

0.08

215

619

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

195

358

3.58

51.62

1.0

1.1

ug/l

80.8

83.6

0.37

174

280

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

1046

4079

1.69

51.52

1.1

g/l

1.5

1.36

938

3699

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1068

4216

1.67

50.27

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1981

9003

1.46

50.12

2.2

2.4

g/l

0.8

0.9

0.37

1700

7764

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

245

535

3.01

49.69

1.8

2.1

umol/l

15.0

17.1

2.17

245

535

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

981

3798

1.70

49.62

1.7

1.5

—

(3019977) pH of Arterial blood

475

1441

2.17

49.58

2.5

7.4

0.91

190

468

(3014765) Yersinia sp identified in Stool by Organism specific culture

1951

8905

1.45

48.25

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

990

3885

1.68

47.66

1.5

1.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1465

6329

1.53

47.44

1.2

u/ml

6.4

5.3

0.16

107

486

(42529406) Shigella sp [Presence] in Stool by Culture

1950

8930

1.45

47.39

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

3224

16056

1.33

47.37

1.4

1.3

iu/l

25.9

29.1

6.71

2691

13974

(44813793)

616

2097

1.93

47.31

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

618

2107

1.93

47.25

1.6

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1925

8838

1.44

46.15

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1416

6119

1.53

45.80

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

1124

4609

1.61

45.61

3.1

3.3

1.3

1.5

1.06

877

3574

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

827

3133

1.74

45.23

1.7

1.6

—

(3014271) Vancomycin [Susceptibility]

409

1216

2.21

44.89

3.2

2.8

—

(3017569) Oxygen content in Arterial blood

393

1150

2.25

44.79

2.3

2.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

461

1455

2.08

43.62

1.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

585

2016

1.91

43.39

1.6

1.5

umol/l

68.4

70.4

0.28

165

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

400

1205

2.18

42.57

4.1

3.8

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

461

1469

2.06

42.56

1.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1747

8010

1.44

42.17

2.0

2.3

g/l

0.0

0.90

1590

7340

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2536

12394

1.36

42.13

1.1

u/ml

11.4

7.0

0.18

193

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3151

15912

1.31

41.89

10.3

9.7

—

(3037756) Immunofixation for Serum or Plasma

1300

5624

1.53

41.86

1.5

1.7

—

(3038026) Centromere Ab [Units/volume] in Serum

642

2314

1.83

41.50

1.2

u/ml

20.5

55.2

2.02

109

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1386

6093

1.50

41.39

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1386

6094

1.50

41.36

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

500

1661

1.98

41.25

1.5

1.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2425

11811

1.36

41.17

5.4

5.0

1.7

0.76

2298

11036

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1093

4566

1.58

41.09

3.1

nmol/l

0.8

1.78

826

3538

(3008757) Leukocyte morphology finding [Identifier] in Blood

789

3039

1.71

40.74

3.3

3.7

—

(3052851) Hemolysis interference index of Serum or Plasma

1910

8973

1.41

40.31

3.1

3.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1427

6355

1.48

40.02

1.2

u/ml

43.6

43.5

0.00

135

643

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

624

2258

1.82

39.86

1.2

u/ml

61.0

71.6

0.31

111

(3026389) Candida sp identified in Specimen by Organism specific culture

1040

4330

1.58

39.67

1.4

1.3

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

624

2264

1.81

39.52

1.2

u/ml

45.1

46.8

0.06

176

(3008898) HLA-B27 [Presence]

2253

10918

1.37

39.48

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1769

8237

1.42

39.26

1.9

2.2

g/l

38.0

37.8

1.09

1521

7104

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

600

2161

1.83

38.92

1.2

u/ml

4.1

9.7

1.54

158

(3042517) Benzodiazepines panel - Urine

162

323

3.29

38.14

2.8

3.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

222

3472

0.42

37.89

1.1

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1150

4985

1.52

36.73

1.4

1.3

u/l

23.9

28.2

4.71

939

4093

(3022621) pH of Urine by Test strip

3703

19416

1.27

36.69

3.0

2.8

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

429

1408

2.00

36.67

1.5

umol/l

23.9

25.9

0.64

401

1348

(3007930) Methemoglobin/Hemoglobin.total in Blood

2356

11630

1.34

36.60

5.5

5.0

0.9

2.75

2234

10867

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

802

3200

1.65

36.37

1.1

au/ml

37.6

28.0

—

(3004451) EKG impression Narrative

388

1231

2.07

36.33

1.3

—

(3000034) Microalbumin [Mass/volume] in Urine

673

2562

1.73

36.29

3.1

3.0

mg/l

54.7

54.8

0.00

489

1829

(3047007) Chlamydophila sp Ab [Presence] in Serum

1046

4455

1.55

36.20

1.3

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

357

1100

2.13

36.03

2.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1852

8827

1.39

35.92

1.1

u/ml

4.5

5.7

0.76

218

1177

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

786

3130

1.65

35.92

1.1

au/ml

85.2

62.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

616

2293

1.77

35.90

1.2

1.3

mmol/l

2.0

2.1

2.26

564

2126

(3020491) Glucose [Moles/volume] in Blood

583

2144

1.79

35.39

1.8

1.7

mmol/l

6.9

6.8

0.38

393

1595

(4198724)

428

1424

1.98

35.25

2.5

2.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1041

4457

1.54

35.20

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2040

9914

1.36

35.09

1.2

1.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

662

2542

1.71

34.65

1.6

1.5

promille

1.3

1.4

0.86

483

1994

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1587

7425

1.41

34.30

2.0

2.3

g/l

0.0

0.93

1433

6780

(3047181) Lactate [Moles/volume] in Blood

1917

9270

1.37

34.03

6.3

5.7

mmol/l

1.3

0.94

1714

8168

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

754

3023

1.64

33.60

1.7

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

694

2726

1.68

33.45

1.5

30.6

31.5

0.25

389

1755

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

479

1688

1.87

33.36

1.5

1.4

u/l

6.0

5.9

0.13

413

1410

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1560

7325

1.41

33.04

2.0

2.3

g/l

0.0

0.00

1429

6761

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

601

2284

1.73

32.67

1.1

mg/l

289.9

419.3

0.50

534

2054

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1214

5466

1.46

32.28

1.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1058

4647

1.50

31.81

1.3

—

(4024509)

647

2533

1.68

31.60

1.7

1.5

—

(3024928) Oxygen saturation in Venous blood

1315

6039

1.44

31.53

4.1

3.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

663

2624

1.66

31.10

3.1

2.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

666

2646

1.66

30.79

3.8

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

672

2677

1.65

30.75

1.4

e6/l

125810.6

101375.8

0.38

462

1843

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

956

4140

1.52

30.75

1.3

mmol/l

7.5

7.1

3.27

718

2979

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

311

969

2.11

30.62

1.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

387

1309

1.94

30.51

2.1

2.3

ug/l

102.2

206.7

0.43

369

1246

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1355

6301

1.42

30.34

1.1

u/ml

1.0

1.7

2.62

578

2507

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

699

2826

1.63

30.20

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1370

6398

1.41

29.96

1.5

1.6

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

628

2475

1.67

29.95

1.2

1.1

mg/l

39.0

44.5

1.96

504

2102

(3017354) Segmented neutrophils/100 leukocytes in Blood

698

2827

1.63

29.95

3.0

3.3

58.6

0.02

468

1804

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

827

3489

1.56

29.93

1.1

iu/ml

1.4

2.1

0.93

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

608

2385

1.68

29.52

1.1

mg/l

266.2

274.1

0.31

525

2109

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

685

2772

1.63

29.50

1.7

—

(3044941) Cell count panel - Synovial fluid

1014

4491

1.49

29.32

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1368

6414

1.41

29.25

1.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

397

1378

1.89

29.04

1.6

mmol/24h

5.9

5.6

0.17

116

(3016018) Differential panel - Cerebral spinal fluid

781

3284

1.57

28.70

1.4

1.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

758

3167

1.58

28.63

1.2

u/l

60.2

65.3

0.91

490

2163

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

609

2413

1.66

28.49

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

609

2413

1.66

28.49

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

609

2413

1.66

28.49

1.6

1.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

583

2286

1.68

28.38

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

376

1296

1.91

28.10

1.3

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

376

1297

1.91

28.04

1.3

1.5

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

415

1481

1.84

27.90

1.1

u/l

21.2

26.5

1.07

333

1123

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

414

1481

1.84

27.63

1.1

u/l

82.4

87.8

0.63

345

1165

(3003888) Timothy IgE Ab [Units/volume] in Serum

1225

5691

1.42

27.61

1.1

u/ml

4.3

5.2

1.16

606

2919

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

585

2315

1.66

27.52

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1036

4683

1.46

27.07

1.1

—

(4306422)

1039

4703

1.46

26.95

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1343

6371

1.39

26.85

1.4

u/ml

17.8

20.5

0.27

124

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1168

5415

1.42

26.65

1.1

u/ml

0.8

1.2

1.69

470

2283

(3004775) Volume in Urine collected for unspecified duration

566

2241

1.66

26.60

2.2

2.3

661.0

681.3

0.51

364

1562

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1007

4550

1.46

26.38

1.1

123.3

117.7

5.72

910

4131

(3018851) Theophylline [Moles/volume] in Serum or Plasma

106

205

3.39

26.30

1.8

umol/l

44.1

47.6

0.52

106

205

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1336

6356

1.39

26.27

1.2

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1319

6274

1.39

25.97

4.0

3.2

mg/l

24.9

26.9

0.98

786

3975

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

879

3878

1.49

25.96

6.8

6.1

mg/l

11.2

11.5

1.13

796

3577

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1032

4734

1.44

24.99

1.3

1.2

u/ml

4.1

3.8

0.30

437

2124

(3016650) Hepatitis A virus Ab [Presence] in Serum

1119

5214

1.41

24.85

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1539

7568

1.34

24.57

1.7

1.9

iu/l

9.9

12.3

0.13

518

2840

(3019230) Fractional oxyhemoglobin in Venous blood

1067

4940

1.42

24.57

4.2

3.0

66.8

64.6

2.85

1062

4918

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

488

1898

1.69

24.57

1.5

u/ml

25.3

24.2

0.13

378

(3016750) Collection duration of Urine

437

1649

1.74

24.51

2.1

2.2

min

498.3

500.0

0.13

303

1254

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

674

2844

1.56

24.48

1.5

1.6

—

(3051593) INR in Capillary blood by Coagulation assay

338

1180

1.88

24.40

8.5

9.8

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

214

630

2.23

24.35

1.2

pmol/l

351.9

315.2

0.19

150

475

(3037556) Urate [Mass/volume] in Serum or Plasma

239

738

2.13

24.21

1.4

1.3

—

(4027681)

487

1903

1.68

24.11

1.3

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1253

5984

1.38

24.11

1.3

u/ml

279.1

266.8

0.73

783

3908

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1105

5166

1.41

24.10

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

409

1523

1.76

24.02

1.3

umol/l

4.5

4.9

0.65

353

1415

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

393

1449

1.78

23.87

1.8

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

393

1449

1.78

23.87

1.8

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

393

1449

1.78

23.87

1.8

1.9

—

(3008037) Lactate [Moles/volume] in Venous blood

1253

5994

1.38

23.87

3.6

3.0

mmol/l

1.6

0.07

1227

5865

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

179

492

2.39

23.79

2.5

2.4

mmol/l

7.5

7.4

0.06

116

285

(3006270) Folate [Moles/volume] in Blood

573

2346

1.61

23.66

1.2

1.1

nmol/l

361.0

371.1

0.52

484

1991

(3001019) Free T4 and TSH panel - Serum or Plasma

3224

17470

1.22

23.50

1.7

1.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1628

8127

1.32

23.46

1.2

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

392

1452

1.77

23.46

1.8

1.9

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

297

1009

1.93

23.27

1.5

1.4

pmol/l

14.2

15.1

2.06

254

841

(3000012) Reticulocyte production index

396

1475

1.76

23.26

1.4

1.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1916

9793

1.29

23.21

1.7

1.6

iu/ml

7.4

6.8

0.05

370

2099

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1051

4914

1.41

22.93

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

376

1387

1.78

22.83

1.5

3.5

4.1

0.33

327

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1117

5286

1.39

22.73

1.1

u/ml

1.8

2.2

0.54

285

1301

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

447

1735

1.69

22.72

1.3

1.4

—

(3038515) Glucose [Moles/volume] in Venous blood

1177

5622

1.38

22.65

3.8

3.1

mmol/l

7.5

0.28

1155

5518

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

357

1300

1.80

22.62

2.1

ug/min

88.4

108.6

0.25

299

(3036489) Thrombin time

2235

11705

1.26

22.25

2.0

2.1

21.4

21.5

0.14

1892

10207

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

452

1770

1.68

22.25

1.3

1.4

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

338

1218

1.82

22.17

1.6

1.8

umol/l

2.0

0.74

313

1145

(3008295) Osmolality of Serum or Plasma

638

2725

1.54

22.02

1.5

1.4

mosm/kgh2o

282.6

278.9

3.51

492

2134

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

291

1002

1.91

21.96

1.5

1.4

mu/l

701.1

719.9

0.03

278

951

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

295

1023

1.89

21.80

1.5

1.4

73.7

72.5

0.69

282

972

(3001186) Copper [Moles/volume] in Serum or Plasma

224

704

2.09

21.76

1.4

1.3

umol/l

17.0

16.9

0.23

203

622

(3044242) Glucose [Moles/volume] in Arterial blood

343

1251

1.80

21.65

2.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

409

1574

1.71

21.48

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1036

4894

1.39

21.33

1.3

1.2

u/ml

3.3

3.8

0.47

346

1700

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

137

2055

0.44

21.30

1.4

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

504

2056

1.61

21.19

1.3

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

501

2042

1.61

21.14

1.3

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

424

1659

1.68

20.97

1.3

titre

495.1

415.4

0.14

111

(3039443) Prostate specific Ag panel - Serum or Plasma

1144

5511

1.37

20.93

1.6

—

(40762365) Oxygen content in Arterial blood by calculation

154

420

2.41

20.89

2.7

3.0

ml/dl

15.1

14.7

0.79

142

391

(21494890) Protein electrophoresis panel - 24 hour Urine

652

2840

1.51

20.60

1.8

2.2

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

420

1650

1.67

20.48

2.4

2.6

u/ml

925.2

1075.9

0.64

411

1632

(3003181) Sodium [Moles/volume] in Urine

1000

4732

1.39

20.41

1.4

mmol/l

62.9

63.0

0.01

785

3743

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

458

1843

1.63

20.37

1.5

1.6

u/l

6.6

6.1

0.28

203

921

(3017817) Protein [Mass] in Urine collected for unspecified duration

601

2579

1.53

20.36

2.3

2.6

1.3

0.4

—

(3022689) Creatine [Moles/volume] in Urine

240

795

1.98

20.29

1.5

—

(21494755) Public health laboratory ask at order entry panel

4791

36016

0.86

20.16

1.4

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

912

4260

1.41

20.08

1.1

u/ml

3.8

5.0

1.40

380

1762

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1212

5934

1.35

20.00

1.5

u/ml

108.3

112.3

0.59

339

1283

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

411

1618

1.67

19.90

1.3

titre

99.7

70.6

0.37

134

(3014133) Dog dander IgE Ab [Units/volume] in Serum

963

4548

1.39

19.90

1.1

u/ml

4.6

4.5

0.04

388

1776

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

434

1736

1.64

19.78

1.0

ng/l

363.2

328.4

0.16

304

1242

(3019420) Tryptase [Mass/volume] in Serum or Plasma

412

1627

1.66

19.72

1.4

1.5

ug/l

7.1

8.2

1.17

365

1485

(3036603) Volume of Urine

481

1977

1.60

19.66

1.6

1949.6

1931.9

0.07

108

460

(3010015) Selenium [Moles/volume] in Serum or Plasma

218

2.95

19.61

2.0

1.9

umol/l

1.3

0.16

189

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

4.45

19.58

1.3

1.4

nmol/l

579.5

476.3

0.57

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1747

9025

1.28

19.51

2.4

2.6

188.2

186.9

0.24

1641

8564

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

380

1474

1.69

19.46

1.2

1.3

61.8

61.4

0.02

178

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1893

9881

1.26

19.41

2.1

2.4

94.7

91.7

7.35

1742

9221

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

435

1751

1.63

19.35

1.0

ng/l

37.3

43.0

1.99

297

1231

(37021550) Renin [Units/volume] in Plasma --upright

183

557

2.16

19.34

1.2

1.3

mu/l

69.9

83.0

0.28

135

423

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

434

1748

1.63

19.26

1.0

ng/l

785.2

728.5

1.69

301

1198

(3004716) Salmonella sp identified in Stool by Organism specific culture

2970

16278

1.21

19.25

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

368

1422

1.70

19.12

1.1

—

(3020650) Glucose [Presence] in Urine

228

759

1.97

19.05

1.4

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

201

640

2.06

18.96

1.3

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

490

2050

1.57

18.62

1.9

1.7

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

418

1688

1.63

18.39

1.1

u/l

1.1

0.29

185

769

(3033923) Metanephrine [Moles/time] in 24 hour Urine

184

575

2.10

18.24

1.1

umol/24h

0.6

3.2

0.55

301

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

687

3103

1.46

18.21

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

404

1622

1.64

18.20

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1010

4881

1.36

18.18

1.1

au/ml

13.1

11.1

0.24

318

(3023410) Appearance of Cerebral spinal fluid

685

3096

1.46

18.10

1.6

—

(3041354) Potassium [Moles/volume] in Venous blood

725

3313

1.44

18.08

2.6

2.3

mmol/l

4.0

0.27

719

3287

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

308

1151

1.76

18.04

2.0

2.1

—

(3035285) Chloride [Moles/volume] in Venous blood

724

3313

1.44

17.92

2.6

2.3

mmol/l

105.9

105.7

0.79

718

3286

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

291

1072

1.78

17.89

1.2

g/l

0.3

0.48

225

857

(3033705) Calcium.ionized [Moles/volume] in Venous blood

713

3255

1.44

17.88

2.7

2.3

—

(3032057) Clostridioides difficile [Presence] in Stool

178

554

2.11

17.84

1.9

1.8

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

178

554

2.11

17.84

1.3

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

735

3378

1.43

17.78

1.2

1.1

99.5

95.4

3.74

690

3171

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

253

897

1.85

17.60

1.2

1.3

25.6

20.2

0.46

159

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

364

1437

1.66

17.52

1.2

u/ml

9.5

11.5

0.13

142

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

303

1137

1.75

17.51

1.9

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

303

1138

1.75

17.46

1.9

2.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

218

738

1.94

17.42

1.4

1.2

nmol/l

109.3

133.1

1.59

168

538

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

471

1986

1.56

17.35

1.2

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

212

712

1.95

17.34

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

4156

31229

0.86

17.27

1.7

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

270

990

1.79

16.89

1.2

108.1

112.3

1.62

236

889

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

966

4714

1.35

16.38

1.5

1.4

nmol/l

0.3

0.4

1.33

738

3654

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

129

365

2.32

16.28

1.1

1.2

—

(3000330) Specific gravity of Urine by Test strip

2609

14360

1.20

16.18

3.7

3.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

233

833

1.84

15.86

2.7

2.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

233

833

1.84

15.86

2.7

2.6

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

815

3898

1.38

15.73

1.2

u/ml

52.0

53.1

0.04

264

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

305

1187

1.69

15.56

1.6

1.8

umol/l

29.7

29.0

0.63

295

1142

(1761482) Bacteria [#/volume] in Urine by Culture

1376

7121

1.27

15.24

4.4

3.9

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

449

1932

1.53

15.18

1.1

iu/ml

9.7

8.3

0.35

511

(3000093) Morphology [Interpretation] in Blood Narrative

602

2752

1.44

15.08

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

599

2738

1.44

15.02

1.2

1.3

mmol/l

12.3

11.8

0.55

174

716

(3011436) Histone Ab [Units/volume] in Serum

180

603

1.96

14.91

1.1

u/ml

—

36.9

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

198

686

1.89

14.88

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

208

733

1.86

14.84

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

444

1916

1.52

14.83

1.2

1.1

ratio

1.1

0.36

162

665

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

455

1977

1.51

14.72

1.4

u/l

12.7

12.6

0.07

438

1910

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

208

738

1.85

14.55

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

212

767

1.81

13.96

1.5

1.4

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

276

1078

1.68

13.96

2.2

2.5

nmol/l

142.4

151.2

0.73

252

915

(3024263) Appearance of Synovial fluid

358

1493

1.57

13.95

1.7

1.8

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

489

2183

1.47

13.91

1.4

umol/l

12.3

12.1

0.32

462

2071

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

206

742

1.82

13.77

1.1

—

(4268621)

680

3230

1.38

13.76

2.4

2.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

207

748

1.82

13.70

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

560

5137

0.71

13.61

3.2

3.6

u/ml

22.7

38.9

6.50

535

4956

(3021879) Hepatitis B virus core Ab [Presence] in Serum

4257

24682

1.14

13.59

1.4

1.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

186

652

1.87

13.54

1.1

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

424

4072

0.68

13.37

1.4

1.3

ug/l

4.1

3.6

0.38

340

3562

(40762814) Titanium [Mass/volume] in Blood

136

429

2.08

13.32

2.3

ug/l

5.0

3.4

0.89

152

(3035947) Staphylolysin Ab [Units/volume] in Serum

354

1490

1.56

13.29

1.2

1.1

iu/ml

3.7

4.2

0.40

119

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

7334

52439

0.90

13.27

1.5

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

382

1638

1.53

13.21

1.3

1.2

u/l

312.4

311.0

0.01

353

1532

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

239

2.47

13.11

1.1

1.2

mg/l

43.2

49.4

0.89

(46235355) HIV 1 and 2 tests - Meaningful Use set

9871

60064

1.09

12.94

2.0

1.9

—

(3006462) Nitrate [Presence] in Urine

330

1380

1.57

12.76

3.2

3.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

564

2631

1.41

12.73

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

236

908

1.71

12.67

1.0

u/ml

9.2

10.9

0.29

112

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

959

4858

1.30

12.64

2.9

2.8

u/ml

11357.4

4811.9

0.30

257

(3011412) CD3 cells [#/volume] in Blood

630

2999

1.38

12.63

2.1

2.5

e9/l

1.3

1.1

2.32

374

1780

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

221

2.49

12.50

1.0

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

252

991

1.67

12.49

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

757

3718

1.34

12.44

1.1

1.0

u/ml

0.3

0.5

0.52

175

795

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1723

9355

1.21

12.41

2.5

2.7

g/l

3.8

3.6

7.28

1621

8948

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

279

1129

1.62

12.38

2.4

2.3

—

(44806420)

190

693

1.80

12.27

2.2

2.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1226

6428

1.26

12.26

6.0

5.7

iu/ml

5103.1

1032.9

0.56

171

971

(3046904) Somatotropin [Units/volume] in Serum or Plasma

4.84

12.20

3.2

1.4

mu/l

2.1

0.01

(4211845)

353

1515

1.53

12.20

3.1

2.9

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

299

1237

1.59

12.14

2.3

2.4

umol/l

56.6

53.0

1.11

254

1021

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1129

5870

1.27

12.13

2.8

3.4

u/ml

452.1

876.4

1.39

1026

5325

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

206

774

1.75

12.05

1.2

—

(3039000) Anion gap in Blood

1255

6612

1.25

12.04

7.5

6.7

mmol/l

11.3

11.2

0.86

1153

5937

(3018572) Chloride [Moles/volume] in Blood

1255

6613

1.25

12.03

7.5

6.7

mmol/l

104.7

105.2

2.45

1153

5939

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

544

2549

1.40

12.00

1.2

titre

159.2

187.8

0.35

431

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

145

489

1.95

11.91

2.3

2.6

mg/l

74.2

42.0

0.76

(44790049)

678

3298

1.35

11.90

1.6

1.5

—

(44790048)

678

3299

1.35

11.88

1.6

1.5

—

(44790047)

678

3299

1.35

11.88

1.6

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

365

1588

1.51

11.86

1.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

425

1910

1.46

11.78

1.0

—

(44806118)

677

3298

1.35

11.78

1.6

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

261

1053

1.63

11.75

1.1

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

541

2543

1.40

11.73

1.2

titre

210.5

171.1

0.18

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

336

1441

1.53

11.68

2.0

1.9

145.7

142.8

0.25

311

1362

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

326

1390

1.54

11.64

1.0

1.1

103.8

96.7

4.06

256

1111

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.52

11.51

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

176

646

1.79

11.18

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1396

7503

1.22

11.17

1.3

—

(3026470) Cobalt [Mass/volume] in Blood

374

1660

1.48

11.08

2.0

ug/l

3.4

3.8

0.45

320

1465

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

287

1207

1.56

10.92

1.1

ng/l

1241.8

446.8

0.57

283

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

5798

34695

1.11

10.69

2.1

2.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

273

2.21

10.59

1.9

2.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

275

1156

1.56

10.51

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

379

1707

1.46

10.46

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

293

1251

1.54

10.46

6.0

4.8

mg/l

3880.1

2183.0

0.47

192

917

(3010503) CD19 cells [#/volume] in Blood

406

1855

1.44

10.39

2.2

2.7

e9/l

0.3

0.06

396

1810

(3036670) Protein [Mass/volume] in Synovial fluid

208

819

1.67

10.36

1.3

1.2

g/l

40.3

39.8

0.16

105

455

(3016038) Potassium [Moles/volume] in Urine

392

1781

1.45

10.34

1.3

1.2

mmol/l

32.3

34.5

1.16

334

1538

(3012494) Peanut IgE Ab [Units/volume] in Serum

217

866

1.64

10.27

1.1

u/ml

12.3

7.6

0.16

117

473

(3036180) Methadone [Presence] in Urine

3.93

10.26

1.9

3.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

683

3410

1.32

10.13

2.9

3.4

nmol/l

6.5

7.5

0.24

661

3310

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

284

1214

1.54

10.10

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

142

505

1.84

10.04

1.0

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

310

2.09

10.02

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

722

3641

1.30

9.97

1.3

1.2

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

126

432

1.91

9.95

4.6

5.1

ug/min

41.5

45.9

0.31

346

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

245

1017

1.58

9.92

1.1

92.6

90.0

0.62

107

487

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

433

2021

1.41

9.88

2.7

3.4

nmol/l

112.9

133.5

0.56

423

1987

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

154

565

1.79

9.87

5.3

6.1

66.1

71.3

1.57

117

454

(3025577) Chromium [Mass/volume] in Blood

358

1615

1.46

9.83

2.0

2.1

ug/l

2.2

2.4

0.58

282

1371

(42529582) MDA5 Ab [Presence] in Serum by Line blot

183

707

1.70

9.81

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

183

707

1.70

9.81

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

183

707

1.70

9.81

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

183

707

1.70

9.81

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

222

2274

0.64

9.80

1.4

1.6

mmol/l

8.7

7.7

4.46

135

1385

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

114

381

1.96

9.70

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

3.28

9.70

2.1

1.9

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

754

3841

1.29

9.66

1.7

1.9

titre

3693.8

4194.3

0.09

182

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

300

2.08

9.44

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

221

908

1.60

9.37

1.3

1.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

3.76

9.14

6.2

4.9

mmol/l

0.3

0.2

0.14

(3045716) Anion gap in Serum or Plasma

292

1285

1.49

9.12

3.0

2.3

mmol/l

8.8

9.2

1.41

216

934

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

471

2264

1.37

9.06

1.7

1.9

mg/l

3.8

3.7

0.20

441

2169

(3028433) Virus identified in Specimen by Culture

234

983

1.56

9.05

1.1

1.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

244

1035

1.55

9.05

1.2

1.1

113.7

107.5

1.54

211

943

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

236

994

1.56

9.03

1.1

95.4

90.7

1.01

104

480

(40757494) Bilirubin.total [Moles/volume] in Blood

339

1541

1.44

9.00

2.2

umol/l

24.5

41.3

1.43

149

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

173

675

1.68

8.99

1.1

—

(3018133) Calcium [Moles/volume] in Urine

125

443

1.85

8.99

2.1

1.8

mmol/l

2.8

2.6

0.45

112

400

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

881

4621

1.25

8.93

1.1

u/ml

3.4

2.8

0.51

399

2283

(3028717) Thiamine [Mass/volume] in Blood

295

2.05

8.81

1.3

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

639

3230

1.30

8.74

1.1

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

184

737

1.64

8.68

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

240

1026

1.53

8.62

2.0

1.6

u/ml

70179.6

14841.2

0.62

132

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

351

1621

1.42

8.58

1.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

519

2556

1.33

8.56

1.3

mmol/l

6.4

6.3

0.67

475

2372

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

431

2067

1.37

8.45

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

432

2077

1.37

8.35

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

112

393

1.87

8.34

1.2

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

320

1.97

8.31

1.1

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

3.58

8.28

2.1

1.4

nmol/l

201.2

377.8

0.88

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

352

1641

1.41

8.19

1.7

u/field

2.7

2.4

0.33

266

1170

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

158

2.41

8.19

1.2

1.1

u/field

1.2

0.06

108

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

388

1840

1.38

8.17

1.2

u/l

78.7

93.6

2.84

341

1612

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

446

2166

1.35

8.10

2.1

2.6

e6/l

543.5

530.9

0.14

385

1796

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

499

2466

1.33

8.07

1.4

1.3

u/l

523.9

500.9

0.06

466

2344

(43055442) Apixaban [Mass/volume] in Serum or Plasma

333

1.93

8.05

1.4

1.6

ug/l

99.1

115.1

0.82

274

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

124

2.59

8.03

1.2

1.3

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

197

2.23

8.00

1.1

u/l

8.6

10.6

0.44

197

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

432

2095

1.35

7.93

2.1

2.7

e9/l

0.3

0.2

1.10

380

1795

(3017704) Immunofixation for Urine

325

1504

1.42

7.90

1.5

1.7

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

232

1006

1.51

7.86

1.6

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

447

2183

1.34

7.85

2.8

2.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

996

5373

1.22

7.84

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

414

2001

1.36

7.78

1.0

1.1

u/ml

2.9

1.5

0.37

127

551

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

354

1669

1.39

7.75

1.3

mmol/l

5.9

5.7

3.91

329

1582

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

376

1791

1.38

7.74

1.2

u/l

21.8

24.9

0.68

326

1544

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

243

1068

1.49

7.73

2.4

2.0

ug/l

60.9

59.2

0.14

238

1044

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2961

21596

0.89

7.71

1.5

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

452

2218

1.34

7.70

1.8

2.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

461

2271

1.33

7.65

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

697

3627

1.26

7.64

1.5

1.4

g/l

33.9

33.1

1.03

633

3271

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

321

1.92

7.63

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

560

0.37

7.59

1.1

1.2

—

(3027035) Albumin [Mass/time] in 24 hour Urine

263

2.02

7.57

1.5

1.3

mg/24h

227.8

266.8

0.09

(3051339) Copper [Moles/volume] in Blood

140

2.44

7.55

1.1

1.2

umol/l

17.1

16.7

0.22

120

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

112

407

1.80

7.53

1.3

1.4

52.0

52.5

0.03

209

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

129

489

1.73

7.53

1.3

1.4

ng/l

85.8

275.0

0.59

324

(4034850)

1749

9946

1.16

7.49

10.7

9.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

663

3440

1.27

7.46

1.6

iu/ml

28.1

34.9

0.87

165

(40761995) Spermatozoa Progressive [#/volume] in Semen

997

0.53

7.44

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

996

0.53

7.42

6.4

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

3.63

7.34

1.6

1.3

nmol/l

136.1

131.9

0.05

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

317

1.90

7.30

1.9

2.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

154

1595

0.63

7.29

1.4

nmol/l

26.8

31.1

0.92

130

1444

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

466

2319

1.32

7.24

1.8

2.0

u/field

1.8

2.3

1.15

232

1019

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

206

2.13

7.23

1.3

1.2

38.8

18.3

1.10

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

168

2.26

7.21

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

859

4609

1.22

7.18

2.1

2.2

titre

7.3

6.9

0.04

145

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

6292

38452

1.08

7.17

2.2

2.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

112

2.58

7.17

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1257

6991

1.18

7.16

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

400

1951

1.35

7.13

1.3

u/l

13.8

14.3

0.16

370

1799

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

237

1055

1.47

7.12

2.1

1.9

159.4

166.7

0.51

219

1005

(1175426) CD3 cells/100 lymphocytes in Blood

479

2400

1.31

7.10

1.9

2.1

72.5

72.7

0.10

461

2304

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

238

1062

1.47

7.07

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

472

2364

1.31

7.02

1.8

2.1

13.9

14.2

0.20

214

1098

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

556

2847

1.28

7.00

3.7

5.0

u/ml

78.8

113.0

0.64

163

879

(3013466) aPTT in Blood by Coagulation assay

179

2.20

6.98

1.1

36.7

37.0

0.08

153

(44806071)

109

403

1.77

6.96

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

304

1.90

6.95

2.7

2.3

mmol/l

1.3

1.2

0.13

212

(3051611) Lipemic interference index of Serum or Plasma

607

3146

1.27

6.94

3.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

483

2433

1.30

6.90

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

482

2429

1.30

6.87

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

195

841

1.52

6.84

1.6

ug/l

10.2

8.7

3.94

195

841

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

411

2027

1.33

6.83

12.9

13.5

nmol/l

778.7

1333.4

0.59

395

1955

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

482

2431

1.30

6.83

1.2

—

(3007463) Buprenorphine [Presence] in Urine

123

2.45

6.82

7.7

7.9

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

115

435

1.73

6.81

1.5

1.4

nmol/l

0.2

0.3

1.61

303

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

162

671

1.58

6.79

1.5

1.6

ug/l

0.4

1.13

104

447

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

431

2143

1.32

6.77

17.1

19.0

nmol/l

1385.5

2941.0

1.05

410

2047

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

241

1089

1.45

6.74

2.7

2.9

umol/l

28.3

28.7

0.17

175

834

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

477

2410

1.30

6.68

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

476

2407

1.30

6.63

1.2

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

134

2.35

6.51

1.6

2.0

nmol/l

2.0

11.9

1.64

124

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

476

2414

1.29

6.50

1.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

121

471

1.68

6.49

1.1

pmol/l

3.5

3.9

0.10

(3020911) Cortisol [Moles/time] in 24 hour Urine

3.59

6.43

1.1

nmol/24h

106.3

97.5

0.17

(3023383) Lactate [Moles/volume] in Pleural fluid

187

811

1.51

6.43

1.3

mmol/l

3.9

3.4

1.24

170

750

(3001556) Androgen free Index in Serum or Plasma

294

1.87

6.42

1.6

1.2

—

(3006576) Bicarbonate [Moles/volume] in Blood

225

1014

1.46

6.41

5.6

6.4

mmol/l

25.4

25.0

0.71

209

913

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

356

1737

1.35

6.39

1.2

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

240

1.97

6.34

1.7

1.6

mg/l

0.8

2.0

1.82

153

(3012441) Differential panel - Pleural fluid

542

2807

1.27

6.28

1.5

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

109

417

1.71

6.24

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

152

636

1.57

6.16

1.4

23.0

22.8

0.03

128

526

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

212

953

1.46

6.14

2.5

3.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

113

439

1.69

6.13

1.1

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

234

1.96

6.13

1.7

1.6

mg/l

2.2

2.1

0.11

168

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

234

1.96

6.13

1.7

1.6

mg/l

0.7

1.0

0.57

151

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

234

1.96

6.13

1.7

1.6

mg/l

1.9

2.7

0.69

165

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

234

1.96

6.13

1.7

1.6

mg/l

2.1

2.5

0.24

152

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

234

1.96

6.13

1.7

1.6

mg/l

0.7

1.5

1.66

141

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

234

1.96

6.13

1.7

1.6

mg/l

3.8

3.7

0.04

144

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

234

1.96

6.13

1.7

1.6

mg/l

1.5

2.2

0.53

146

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

234

1.96

6.13

1.7

1.6

mg/l

1.5

2.0

0.57

164

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

234

1.96

6.13

1.7

1.6

mg/l

1.3

2.0

0.62

140

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

259

1211

1.40

6.07

1.0

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

566

2961

1.25

6.05

1.5

1.4

e6/l

83770.8

49621.4

1.31

340

1771

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

324

1.80

6.04

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

857

0.55

6.01

2.3

2.9

—

(3048879) Bone marrow aspiration report

183

803

1.49

5.99

1.5

1.9

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

218

1.98

5.99

1.3

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

619

3276

1.24

5.97

1.5

e6/l

3088.0

3452.1

0.17

448

2374

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

179

2.09

5.91

1.2

1.1

—

(3007916) DNA double strand Ab [Titer] in Serum

375

1.73

5.90

1.3

1.4

titre

125.0

155.7

—

(3019174) dRVVT (LA screen)

270

1.87

5.89

1.2

—

(3042733) HLA Ab [Presence] in Serum

236

1092

1.42

5.88

5.3

4.9

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

213

969

1.44

5.82

1.0

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

198

893

1.45

5.68

1.4

56.6

54.3

0.36

163

767

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

212

0.25

5.68

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.77

5.66

1.1

1.3

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

2.77

5.66

1.9

1.4

nmol/l

214.5

279.2

0.33

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

203

922

1.44

5.62

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

256

1.87

5.60

1.0

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

372

1866

1.31

5.59

1.7

2.2

98.7

98.0

0.16

331

1757

(37019676) Renin [Units/volume] in Plasma --supine

2.99

5.58

1.0

1.1

mu/l

55.0

59.8

0.05

(40768441) Liver Pathology biopsy report

443

2274

1.28

5.58

1.3

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

1190

6733

1.16

5.58

2.2

2.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

293

1420

1.35

5.57

1.1

1.2

—

(40768800) Prostate Pathology biopsy report

990

5523

1.18

5.55

1.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

136

2.22

5.55

1.1

1.0

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

107

422

1.66

5.54

1.1

u/ml

0.5

0.3

0.45

268

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

378

1.70

5.51

1.3

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

115

463

1.63

5.51

1.6

1.8

pmol/l

58.5

56.0

0.06

395

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

2.58

5.46

1.0

1.1

g/l

0.2

0.50

(3029075) Extractable nuclear Ab panel - Serum

199

908

1.44

5.40

1.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

241

1.88

5.38

1.3

ml/s/173m2

1.2

1.5

0.41

159

(3015076) Soybean IgE Ab [Units/volume] in Serum

353

1768

1.31

5.38

1.0

u/ml

0.5

0.8

0.54

241

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

106

421

1.65

5.36

2.2

3.2

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

6.01

5.35

1.0

1.1

umol/l

19.5

14.3

0.46

(3047189) Immunofixation for 24 hour Urine

262

1257

1.37

5.33

1.6

1.9

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1040

5850

1.17

5.29

1.5

1.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

262

1.83

5.25

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

183

1704

0.70

5.20

1.8

2.0

—

(40768446) Kidney Pathology biopsy report

261

1259

1.36

5.15

1.7

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

270

1.80

5.06

1.2

1.1

—

(3033942) Copper [Moles/time] in 24 hour Urine

129

2.19

5.04

1.1

1.2

umol/24h

0.8

0.6

0.17

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

191

1.96

5.03

1.0

u/ml

0.3

1.0

0.72

126

(1617658) Protocol used for examination of sentinel lymph nodes

272

2367

0.75

5.03

1.1

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

107

434

1.62

5.02

1.5

1.6

—

(40768806) Pleura Pathology biopsy report

529

2819

1.23

4.89

1.5

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

166

2.01

4.89

1.6

1.7

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

106

2.29

4.84

1.2

1.1

u/field

1.8

1.0

0.55

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

299

1.73

4.81

1.0

u/ml

0.2

0.03

187

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

147

648

1.49

4.80

1.2

98.2

87.4

1.92

184

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

146

643

1.49

4.79

1.2

1.1

79.0

75.7

0.28

176

(3016228) CD19 cells/100 cells in Blood

255

1241

1.35

4.79

1.9

2.1

9.2

8.3

0.48

249

1212

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

128

2.15

4.76

1.6

1.5

u/l

0.2

0.06

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

3.06

4.71

1.1

1.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.41

4.69

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

295

1473

1.31

4.66

1.6

iu/ml

1468366.5

2175676.5

0.50

105

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

387

1.63

4.65

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

322

1.69

4.64

1.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.35

4.59

1.0

1.1

pmol/l

163.9

226.5

0.66

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.35

4.59

1.1

1.2

ng/l

4537.3

2770.0

0.24

(4035726)

4388

26914

1.07

4.58

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

249

1217

1.34

4.57

1.9

2.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.76

4.55

1.7

1.2

—

(3009015) Lactate [Moles/volume] in Synovial fluid

285

1.73

4.52

1.3

1.2

mmol/l

5.2

6.4

1.15

144

(3026250) Tacrolimus [Mass/volume] in Blood

286

1431

1.31

4.48

35.9

35.7

ug/l

7.4

7.3

0.35

252

1314

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

163

1.97

4.46

1.0

u/ml

21.8

17.1

0.21

131

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

192

904

1.39

4.46

1.7

au/ml

85.8

150.8

1.57

117

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

203

965

1.38

4.45

1.9

2.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

403

2108

1.25

4.45

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

173

802

1.41

4.39

1.9

1.7

—

(21491868) Cryoglobulin [Mass/volume] in Serum

220

1065

1.35

4.32

1.2

g/l

0.8

0.5

0.23

(3001686) Cold agglutinin [Titer] in Serum or Plasma

118

509

1.52

4.32

1.3

titre

151.3

154.5

0.01

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

319

1.66

4.32

1.1

—

(3017509) Phencyclidine [Presence] in Urine

365

1.62

4.29

2.3

1.7

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.41

4.26

1.3

1.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

114

490

1.53

4.25

1.1

1.2

u/ml

6.4

2.9

0.24

114

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

279

1406

1.30

4.18

1.7

1.8

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

229

1122

1.34

4.18

1.9

2.0

mg/l

8.0

9.5

4.47

182

896

(3027874) Urate [Moles/volume] in Urine

2.34

4.16

1.0

1.1

mmol/l

1.6

9.5

0.51

(3035880) pH of Pleural fluid

293

1487

1.29

4.16

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

251

1248

1.32

4.15

2.6

2.9

—

(3046861) Legionella sp Ag [Presence] in Urine

145

1.99

4.14

1.2

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

196

1.84

4.13

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

386

2033

1.25

4.06

2.1

1.7

—

(3044009) aPTT.lupus sensitive (LA screen)

285

1.68

4.04

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

379

1993

1.25

4.04

1.0

1.1

u/ml

1.6

2.8

0.67

109

471

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

256

1.72

4.01

1.0

u/ml

0.1

0.6

1.44

151

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

134

604

1.45

4.00

1.2

mg/l

60.4

43.4

0.14

443

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

132

594

1.46

3.97

1.3

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

641

3557

1.18

3.97

1.9

ug/l

19.6

25.9

3.01

628

3489

(3016273) Islet cell 512 Ab [Units/volume] in Serum

204

1.80

3.94

1.0

—

(3003694) ABO and Rh group [Type] in Blood

13924

88468

1.04

3.92

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

778

4393

1.16

3.89

1.1

—

(3034426) Prothrombin time (PT)

218

1073

1.33

3.89

1.2

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

147

681

1.42

3.81

1.4

1.3

112.7

107.6

0.98

138

644

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1756

10450

1.10

3.79

1.3

1.4

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

165

1.87

3.73

1.1

u/ml

8.1

7.5

0.09

117

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.46

3.71

1.8

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

282

1448

1.28

3.71

1.1

miu/ml

1568.5

1518.6

0.31

282

1448

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

161

1.87

3.69

1.0

u/ml

0.3

0.5

0.38

146

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

185

1.81

3.66

1.4

1.3

pmol/l

21.0

15.8

0.41

160

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

181

1.81

3.62

1.0

u/ml

0.5

1.5

0.71

143

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

2.60

3.62

1.1

1.4

e6/l

60.9

55.6

0.04

(3005011) Chlamydia sp Ab [Titer] in Serum

420

1.51

3.57

1.6

—

(3051651) Icteric interference index of Serum or Plasma

346

1831

1.24

3.55

3.9

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

273

1406

1.27

3.53

3.1

3.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

173

1.82

3.53

1.2

1.1

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

2.34

3.51

1.2

1.0

u/field

1.4

1.3

0.07

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

109

2.04

3.49

1.2

1.3

u/field

1.0

1.1

0.11

(40765096) Chromosome analysis panel by Banding

170

822

1.36

3.46

1.2

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

110

493

1.46

3.44

1.4

1.3

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.14

3.44

1.0

—

(3026480) Teichoate Ab [Titer] in Serum

249

1.66

3.40

1.1

—

2.8

—

(3007456) Orange IgE Ab [Units/volume] in Serum

2.39

3.39

1.0

u/ml

0.0

0.2

0.74

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

3.79

3.36

1.2

1.6

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

155

743

1.37

3.35

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

111

502

1.45

3.33

1.1

u/ml

9.1

5.0

0.19

361

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

271

1.62

3.32

1.1

u/l

21.9

20.7

0.20

186

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

382

2059

1.22

3.32

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

292

1.59

3.29

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

375

2023

1.22

3.24

1.1

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

808

4644

1.14

3.24

3.0

2.4

13.2

13.1

2.92

797

4586

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.24

3.23

10.2

7.8

—

(3008536) Aspergillus sp Ab [Presence] in Serum

125

582

1.41

3.22

1.7

2.3

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

218

1.68

3.21

1.2

nmol/l

13.2

15.4

0.41

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.18

3.16

1.1

mmol/l

—

(4133840)

185

920

1.32

3.16

1.2

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

411

1.48

3.15

1.3

1.5

nmol/l

4.7

5.7

1.88

397

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

4640

31996

0.95

3.15

1.9

1.7

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

301

1.57

3.14

1.2

1.1

umol/24h

1.8

2.9

0.45

301

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

2.28

3.10

9.3

8.1

46.4

44.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

270

1414

1.25

3.09

31.1

27.4

ug/l

120.0

117.2

0.26

220

1182

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

424

1.47

3.08

1.3

1.4

nmol/l

424057.6

182293.1

0.53

350

(40765089) Chromosome analysis panel - Blood by G-banded

116

1054

0.72

3.04

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.96

3.04

1.3

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.22

3.02

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

173

1.74

3.00

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

151

736

1.35

2.98

1.3

ug/l

458.8

242.8

0.58

390

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

230

1189

1.27

2.96

1.8

2.1

26.9

29.7

2.39

219

1121

(3045788) Cell count panel - Pleural fluid

459

2548

1.18

2.95

1.5

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

280

1.57

2.95

1.0

1.1

u/ml

1.9

1.8

0.02

210

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

222

1145

1.27

2.92

2.4

2.6

au/ml

132.6

152.2

0.25

155

(3027570) Oxalate [Moles/time] in 24 hour Urine

185

1.70

2.89

1.6

1.4

umol/24h

312.4

337.8

0.40

185

(3008116) Ketones [Moles/volume] in Urine by Test strip

126

600

1.38

2.89

1.6

1.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

272

1.57

2.86

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

145

708

1.34

2.85

1.1

mg/g

6.4

7.3

1.09

137

673

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

427

1.44

2.82

2.4

1.9

—

(3006245) CD3-CD19+ cells/100 cells in Blood

233

1215

1.26

2.81

1.9

2.2

10.5

0.01

217

1125

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

2.26

2.78

1.0

u/ml

0.6

1.0

0.34

(3039744) RNA polymerase III Ab [Units/volume] in Serum

259

1.57

2.76

1.0

1.1

u/ml

9.7

3.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1570

11180

0.92

2.74

1.4

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

199

1.65

2.70

2.6

2.3

—

(3007542) Rye IgE Ab [Units/volume] in Serum

155

1.73

2.66

1.0

1.1

u/ml

0.9

12.1

0.47

(3001964) Herpes simplex virus Ag [Presence] in Specimen

184

940

1.28

2.65

1.7

1.5

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

2.31

2.64

1.2

—

(3002619) Bacteria identified in Specimen by Culture

127

616

1.35

2.64

1.3

1.2

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

221

1.60

2.63

1.2

ug/l

79.1

113.5

1.55

127

(3036071) Salmonella sp Ab [Titer] in Serum

198

1025

1.27

2.58

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

132

647

1.34

2.57

2.5

2.6

—

(3036005) Urine sediment comments by Light microscopy Narrative

2.91

2.56

1.0

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

106

502

1.38

2.56

1.2

mmol/l

1.5

1.7

1.09

308

(3042301) Urate [Moles/volume] in Synovial fluid

2.26

2.55

1.0

umol/l

366.5

353.8

—

(3030313) Adrenal Ab [Titer] in Serum

275

1.53

2.55

1.2

1.0

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

154

774

1.30

2.53

1.3

36.8

39.0

0.28

102

525

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1046

6209

1.11

2.52

1.8

1.6

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

237

1257

1.24

2.51

3.1

mg/l

7.3

8.0

0.72

182

1007

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

292

1.50

2.50

1.0

u/ml

0.1

1.9

0.88

166

(3000690) Aldosterone [Moles/time] in 24 hour Urine

3.69

2.46

1.4

1.1

nmol/24h

33.1

27.4

—

(3012989) Citrate [Moles/time] in 24 hour Urine

2.22

2.46

1.6

1.5

mmol/24h

2.2

2.0

0.44

(3045142) Bone marrow Pathology biopsy report

561

3217

1.14

2.44

1.3

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

121

1.79

2.40

1.2

1.1

mg/l

0.0

0.4

0.51

107

(36303858) Crystals [Presence] in Urine

2.46

2.39

1.1

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

159

1327

0.78

2.37

1.2

—

(40762887) Creatinine [Moles/volume] in Blood

2.18

2.37

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

897

5306

1.11

2.34

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

416

2342

1.17

2.34

2.2

2.6

e6/l

726.5

720.5

0.03

204

915

(3042111) Morphology [Interpretation] in Bone marrow Narrative

802

4718

1.12

2.32

1.5

1.7

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

113

1.80

2.31

1.2

1.5

—

(3015183) Erythrocyte sedimentation rate

306

1683

1.19

2.28

1.2

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

251

1.51

2.27

1.5

1.3

pmol/l

8.7

14.7

1.24

212

(3024932) HLA-DR beta [Type]

206

1090

1.24

2.27

1.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

283

1.48

2.27

1.0

u/ml

0.0

0.4

1.45

159

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.18

2.25

1.2

1.1

2.9

2.3

0.26

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

139

1170

0.78

2.24

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

895

5308

1.11

2.24

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

174

1.62

2.24

1.3

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

141

714

1.29

2.23

1.3

1.4

g/l

14.7

13.3

0.97

111

535

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.91

2.22

1.0

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

285

1.47

2.20

1.0

u/ml

0.8

1.7

0.78

213

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

222

1.54

2.18

2.5

3.8

mg/l

2.4

2.2

0.21

187

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

140

1.69

2.18

1.3

mg/l

1.9

1.6

0.81

118

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

358

2007

1.17

2.16

1.5

1.4

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

161

1.63

2.14

1.6

1.7

umol/l

0.7

0.15

125

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

395

2989

0.87

2.13

3.5

3.8

u/ml

31.6

50.6

2.84

390

2961

(3035611) Eosinophils/100 leukocytes in Synovial fluid

187

1.58

2.12

1.4

1.8

1.3

0.5

0.94

142

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

7846

49880

1.04

2.11

1.7

1.6

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

621

0.71

2.10

2.0

1.8

ug/l

2.7

3.5

0.34

375

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

348

1.41

2.10

1.9

1.7

mg/l

1.7

0.02

293

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

137

1.67

2.08

1.0

u/ml

0.2

0.1

0.28

(3009871) Measles virus Ab [Titer] in Serum

209

1120

1.22

2.08

1.6

1.7

—

(3025315) Body weight

262

1.48

2.08

4.9

4.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

673

3955

1.12

2.04

1.5

—

(3024471) HLA-A [Type]

208

1117

1.22

2.03

1.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1939

11931

1.07

2.03

2.4

2.3

u/l

4748.2

5533.4

0.50

622

4732

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

5267

33273

1.04

1.99

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

709

4185

1.11

1.99

1.1

1.2

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

2.95

1.99

1.1

1.0

—

(21494815) CD4 cells/100 lymphocytes in Specimen

487

2813

1.14

1.97

2.0

2.2

39.4

40.8

0.30

359

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

180

956

1.23

1.97

1.4

59.9

62.2

0.34

144

785

(4281824)

452

3365

0.88

1.95

1.2

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

188

1501

0.82

1.94

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

298

2284

0.85

1.94

1.6

1.8

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

343

1.40

1.93

1.3

u/l

959.0

78.4

0.81

243

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1550

10866

0.93

1.92

2.8

3.6

u/ml

904.7

1958.5

0.78

1313

9346

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

479

1.33

1.89

1.2

1.3

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

121

1.68

1.89

1.4

1.2

g/l

0.1

0.78

(3011544) Albumin [Mass/volume] in Pleural fluid

247

1.46

1.86

1.1

1.2

g/l

18.2

17.1

0.51

226

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

231

1.48

1.86

1.1

iu/ml

14.2

17.7

0.18

(3021691) Plasmodium malariae Ab [Titer] in Serum

2.38

1.83

1.9

2.5

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

726

4313

1.10

1.83

2.7

2.8

u/ml

459.5

759.1

0.36

711

4136

(3000060) B lymphocytes [#/volume] in Blood

169

903

1.23

1.78

1.7

2.1

e6/l

253.1

738.7

0.99

471

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

144

756

1.25

1.78

1.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

2.24

1.76

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

197

1.50

1.74

1.0

1.3

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

176

1.53

1.74

5.3

5.2

—

(3001729) Color of Synovial fluid

224

1.46

1.73

1.4

1.7

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

153

812

1.24

1.73

1.8

1.9

u/l

28.3

40.4

0.56

141

728

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

408

1.33

1.70

1.6

—

(40768793) Breast Pathology biopsy report

980

6951

0.92

1.70

1.3

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

2.13

1.70

1.3

—

(3015531) Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma

4.10

1.68

1.0

u/l

0.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

215

1.46

1.68

5.3

5.5

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

136

1.59

1.67

1.2

1.4

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

178

1.51

1.66

1.0

1.1

u/l

40.1

92.7

0.77

139

(3003338) MCHC [Mass/volume]

42026

277135

0.98

1.66

21.4

16.6

g/l

332.5

332.8

8.23

41790

275076

(40768795) Lymph node Pathology biopsy report

518

3045

1.12

1.63

1.2

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

153

1.54

1.61

1.8

1.7

ng/l

172.8

210.9

2.05

133

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

169

1.51

1.60

1.2

1.4

3.0

1.3

0.67

116

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.71

1.59

1.0

u/ml

0.0

0.2

1.10

(3000919) Neutrophils/100 leukocytes in Pleural fluid

139

739

1.23

1.58

1.4

20.6

22.2

0.29

127

666

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

451

0.71

1.56

2.2

2.5

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

123

1.60

1.56

1.0

u/ml

0.1

0.30

(3018001) Oat IgE Ab [Units/volume] in Serum

208

1.45

1.55

1.1

1.0

u/ml

0.3

0.9

0.39

(3021661) Pineapple IgE Ab [Units/volume] in Serum

2.18

1.55

1.1

1.0

u/ml

0.1

0.2

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

1.67

1.54

1.0

u/ml

0.0

0.2

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

331

1.35

1.52

1.4

72.5

71.1

0.13

274

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

231

1.42

1.52

1.2

1.5

33.4

39.2

0.43

158

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.25

1.51

1.0

1.1

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

3.02

1.50

1.2

1.0

—

(36304079) Mucus [Presence] in Urine sediment

3.02

1.50

1.0

1.1

—

(3022475) Manganese [Moles/volume] in Blood

199

1.45

1.49

1.2

1.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

232

1.41

1.49

2.7

2.5

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

151

816

1.21

1.48

1.4

2.7

0.01

128

683

(3027696) Helicobacter pylori Ab [Titer] in Serum

2.13

1.46

1.2

1.1

titre

1725.8

2278.4

0.47

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

233

1.41

1.46

1.1

1.2

—

(3022229) Phosphate [Moles/volume] in Urine

136

1.54

1.45

2.5

1.9

mmol/l

16.7

19.2

0.45

114

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

201

1.43

1.3

1.5

10.1

12.6

0.37

149

(40758047) Lysozyme [Mass/volume] in Pleural fluid

240

1.39

1.42

1.4

1.1

mg/l

10.0

9.4

0.13

222

(3017950) Salicylates [Moles/volume] in Serum or Plasma

1.83

1.41

4.7

1.6

umol/l

999.8

2241.1

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

2.81

1.40

1.0

1.1

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

2.81

1.40

1.0

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

109

0.48

1.40

1.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

113

597

1.24

1.39

1.2

—

(3045177) Copper [Moles/volume] in Urine

1.95

1.39

1.0

1.1

umol/l

0.4

0.5

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

297

1.35

1.39

1.5

1.2

mmol/l

22.2

20.9

1.00

243

(44786800) Granulocytes/100 leukocytes in Body fluid

331

1.33

1.39

1.3

29.7

23.6

0.65

257

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

117

621

1.23

1.39

1.1

—

(3007700) Barley IgE Ab [Units/volume] in Serum

138

1.52

1.38

1.0

1.1

u/ml

0.6

10.1

0.49

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

348

0.70

1.37

2.0

2.8

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

117

622

1.23

1.37

1.1

—

(3003577) Lead [Moles/volume] in Blood

248

1.37

1.35

1.3

1.4

umol/l

0.2

0.02

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

171

1.46

1.35

1.0

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

155

1.48

1.34

3.6

3.5

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.85

1.31

1.1

1.2

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

1.85

1.31

1.5

1.3

u/field

0.6

—

(3052592) Norovirus Ag [Presence] in Stool

110

585

1.23

1.30

1.2

1.3

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

375

1.29

1.30

3.7

3.2

umol/l

41.7

41.8

0.01

317

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4825

30706

1.03

1.30

3.3

4.1

ug/l

21.0

26.0

0.51

3801

24608

(3016031) Almond IgE Ab [Units/volume] in Serum

200

1.41

1.30

1.0

u/ml

0.2

0.8

2.44

114

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

410

1.28

1.29

3.0

2.6

pmol/l

60.7

74.4

0.41

351

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

484

2880

1.10

1.29

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

169

939

1.18

1.27

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

116

622

1.22

1.27

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

327

1906

1.12

1.27

5.5

6.7

—

(21494434) Karyotype in Bone marrow

424

2512

1.11

1.24

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.66

1.24

1.1

1.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

402

1.27

1.22

1.4

13.7

11.3

0.41

194

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1789

12286

0.95

1.21

1.9

1.8

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

2.46

1.21

1.2

1.0

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.66

1.18

1.5

1.7

ug/l

154.9

123.3

0.20

(3020618) Glucose [Moles/volume] in Synovial fluid

1.57

1.17

1.1

1.0

mmol/l

5.5

4.9

0.43

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

155

1.44

1.16

10.9

10.7

e6/l

637.3

244.3

0.39

116

(3028679) Herpes simplex virus Ab [Presence] in Serum

295

1723

1.12

1.14

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

436

2604

1.10

1.12

1.5

g/l

1.0

0.9

2.06

431

2589

(3009677) Dengue virus Ab [Presence] in Serum

124

1.48

1.11

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

334

1.28

1.07

5.3

7.8

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

104

564

1.21

1.07

3.8

5.0

u/l

46.0

58.4

0.66

211

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

261

0.70

1.05

2.4

2.1

mg/l

2.8

3.1

0.18

253

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.97

1.04

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

131

730

1.18

1.01

1.2

1.3

—

(3024316) Viscosity of Plasma

149

1.41

1.01

1.3

1.9

mpas

1.8

1.7

0.28

(3013762) Body weight Measured

141

0.60

0.99

1.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

189

1.35

0.98

1.1

u/ml

2.0

1.1

0.29

137

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.70

0.97

1.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.74

0.97

1.0

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

184

1.35

0.97

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

264

1.29

0.96

1.5

1.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

552

3893

0.93

0.96

1.7

2.1

umol/l

6.8

7.5

0.58

407

2841

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

173

1.36

0.96

1.1

1.2

—

470.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

162

1.38

0.95

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

370

1.24

0.94

2.7

2.3

u/field

0.6

0.13

370

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

129

1.42

0.94

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1667

10480

1.04

0.94

1.4

1.3

miu/ml

202.5

225.0

1.65

672

4867

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.79

0.94

1.0

1.1

—

(40757373) Influenza virus identified in Isolate

104

573

1.19

0.94

2.2

1.5

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

248

1.29

0.94

2.0

2.2

65.8

58.1

0.64

155

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

125

700

1.17

0.93

1.1

1.2

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

138

0.62

0.92

1.0

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

152

1.38

0.92

1.1

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

1.67

0.92

1.0

u/ml

4.9

0.4

—

(3050794) Legionella sp Ab [Presence] in Serum

267

1.28

0.90

1.1

—

(3034614) HLA Ag [Interpretation]

1.57

0.90

1.0

1.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

274

1.27

0.88

1.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

543

1.18

0.85

1.1

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

166

1.34

0.84

1.8

ug/g

177.0

185.3

0.12

144

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

364

1.22

0.84

1.3

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

209

1225

1.12

0.84

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

335

1.23

0.83

1.4

1.3

—

(3035933) Granulocytes/100 leukocytes in Blood

151

868

1.14

0.83

2.0

1.9

—

(40758358) Immune stain study

133

1.38

0.82

1.0

—

(40759632) Porphyrins [Mass/mass] in Stool

1.75

0.82

1.0

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

114

644

1.16

0.80

1.5

1.3

g/l

26.2

37.4

0.62

495

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

197

1.30

0.79

2.1

2.2

12.0

17.8

0.89

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

100

561

1.17

0.77

4.9

5.6

—

(3041184) Isoniazid [Presence] in Urine

1.69

0.75

1.8

2.6

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.72

0.74

1.9

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.72

0.74

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.72

0.74

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.72

0.74

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.72

0.74

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.72

0.74

2.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.54

0.74

1.0

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

191

0.72

0.74

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

130

748

1.14

0.73

10.3

8.4

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

194

1.28

0.72

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

131

1.35

0.72

22.6

13.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2464

16595

0.97

0.71

2.7

3.4

u/ml

41.6

50.9

1.18

2367

16046

(3038071) Oxygen [Partial pressure] in Mixed venous blood

114

652

1.15

0.70

10.6

8.4

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

1.70

0.69

1.0

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

416

1.18

0.69

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

215

1282

1.10

0.67

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

357

1.19

0.67

1.3

1.4

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

1.41

0.66

6.2

5.8

mg/l

1.2

1.3

0.14

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.41

0.66

1.1

1.2

—

(3028468) Fragments [Presence] in Blood by Light microscopy

1.82

0.66

4.0

1.3

—

(3006598) pH of Arterial cord blood

179

0.73

0.66

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

157

1145

0.90

0.65

1.6

1.4

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

407

1.18

0.64

1.1

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

163

1.29

0.64

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

117

1.34

0.64

1.5

1.6

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

117

0.67

0.63

2.9

2.8

—

(3002853) Influenza virus B Ab [Titer] in Serum

1.72

0.62

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.48

0.61

1.6

2.9

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

501

1.15

0.61

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1595

10775

0.97

0.59

1.5

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

417

1.16

0.59

1.2

1.3

mmol/l

1.2

1.4

0.13

266

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

353

2165

1.07

0.58

1.3

g/l

1.4

1.5

0.31

125

(3013862) HLA-DP [Type]

130

0.71

0.58

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.39

0.58

2.8

3.4

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

241

0.79

0.58

1.6

3.1

pmol/l

4.9

364.4

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

1.42

0.58

2.6

1.5

umol/l

216.1

294.6

0.38

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.50

0.58

1.1

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

1.50

0.58

1.0

1.3

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

1.50

0.58

1.0

1.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

437

1.15

0.57

1.1

—

(40760410) HLA-B [Type] by High resolution

129

0.71

0.56

1.0

—

(40760409) HLA-A [Type] by High resolution

129

0.71

0.56

1.0

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

340

1.18

0.56

2.7

3.1

mg/l

1.2

0.01

228

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.47

0.54

1.1

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

1.51

0.51

1.2

1.3

—

(3049242) von Willebrand panel - Platelet poor plasma

1.32

0.51

1.4

1.7

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.46

0.50

1.0

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

170

0.77

0.50

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3193

21314

0.98

0.50

2.2

2.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

218

1.20

0.49

4.1

4.4

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

110

0.71

0.48

2.2

2.8

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

270

1888

0.94

0.48

2.4

2.8

42.8

38.4

2.37

110

603

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

544

3406

1.05

0.48

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

494

1.13

0.47

4.9

5.7

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

189

0.80

0.45

2.4

3.3

20.0

15.3

—

(4038314)

275

1.17

0.45

1.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.33

0.45

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

1.42

0.42

1.0

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.42

0.0

1.7

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

0.42

0.0

1.4

—

(46236302) HLA-C [Type] by High resolution typing

129

0.76

0.42

1.0

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

198

1.19

0.42

1.1

u/ml

43.6

30.9

—

(3033799) Differential panel - Peritoneal fluid

149

901

1.08

0.41

1.9

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

164

997

1.08

0.40

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

352

1.14

0.40

1.2

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.40

0.39

1.4

1.3

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

142

0.78

0.39

8.1

9.5

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

1.42

0.39

1.8

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

192

0.82

0.39

1.1

—

(40763590) HLA-DQ beta [Type]

127

0.77

0.38

1.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

286

1.15

0.38

1.3

1.2

—

(3014891) Appearance of Pleural fluid

368

1.12

0.36

1.9

1.6

—

(3035082) Kappa light chains [Mass/volume] in Urine

1.31

0.35

1.0

1.1

g/l

0.0

0.2

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

1.29

0.35

1.0

u/l

154.5

380.4

0.98

(46235168) Fasting glucose [Moles/volume] in Blood

394

1.11

0.34

1.2

1.9

mmol/l

6.4

7.4

2.03

136

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.36

0.34

1.0

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

215

1.16

0.34

1.0

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.68

0.34

5.0

4.3

—

(3022670) pH of Venous cord blood

1.33

0.34

1.0

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

258

0.86

0.33

1.0

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

490

1.10

0.32

1.4

1.6

—

(3018291) Platelet Ab [Presence] in Serum

1.37

0.32

1.0

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

223

1.15

0.31

1.0

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

397

1.11

0.31

1.0

—

(3006969) Lambda light chains [Mass/volume] in Urine

1.29

0.30

1.0

1.1

g/l

0.0

0.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

170

1050

1.06

0.30

2.0

e6/l

6643.9

1960.5

0.53

125

701

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

175

1.16

0.29

1.1

1.3

u/l

220.2

1091.5

1.00

155

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

359

2263

1.04

0.29

1.2

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.31

0.28

1.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

671

4515

0.97

0.27

1.6

1.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

568

3617

1.03

0.27

2.4

2.5

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.25

0.26

1.0

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

346

1.10

0.25

2.2

2.7

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

105

0.81

0.25

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

449

1.08

0.23

1.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

149

927

1.05

0.23

2.0

1.9

e6/l

8174.5

11588.3

0.47

491

(4212803)

248

1.11

0.23

1.2

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

286

1.10

0.22

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

155

1.14

0.22

1.1

—

(3020399) Glucose [Mass/volume] in Urine

0.00

0.22

0.0

1.7

—

(3025311) HLA-B [Type]

0.00

0.22

0.0

1.0

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

489

1.07

0.22

3.2

2.7

u/l

1743.4

1698.5

0.02

445

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

106

1.17

0.22

1.1

nmol/l

234.2

282.9

0.44

106

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

0.22

0.0

2.9

—

3.8

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

143

892

1.05

0.21

1.4

1.7

iu/ml

—

25384913.4

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

0.21

0.0

4.7

—

139.4

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

5.3

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

125

1.15

0.21

1.4

1.2

—

(3049233) Organic acids panel - Urine

1.21

0.18

1.1

1.2

—

(40758292) HTLV I+II Ab panel - Serum

543

0.94

0.18

1.3

1.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.18

0.18

1.3

1.0

mmol/24h

148.8

135.7

—

(3000285) Sodium [Moles/volume] in Blood

360

1.07

0.18

1.2

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

102

1.16

0.18

1.0

u/ml

0.7

1.0

0.14

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1097

7292

0.99

0.18

1.4

pmol/l

122.9

133.5

0.33

1064

7120

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.24

0.18

5.5

4.0

—

(3040794) Aluminum [Moles/volume] in Urine

1.19

0.17

2.1

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

420

0.94

0.17

9.3

7.6

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

426

1.06

0.16

1.3

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

191

1.10

0.16

1.1

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.85

0.15

1.0

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

173

1.10

0.15

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

245

1648

0.97

0.14

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

188

1266

0.97

0.12

1.8

1.9

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

400

0.95

0.11

7.3

8.7

umol/l

0.4

0.02

365

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

1.17

0.10

1.0

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1214

7902

1.01

0.08

1.9

1.7

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

208

0.95

0.07

1.6

2.3

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.03

0.07

1.0

1.1

—

(3029612) Listeria sp Ab [Titer] in Serum

1.07

0.07

1.3

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

114

0.92

0.07

1.0

u/ml

0.5

0.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

328

1.04

0.07

1.7

2.4

—

(3044007) Cell count panel - Peritoneal fluid

127

850

0.98

0.07

2.2

1.9

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

253

1635

1.01

0.06

4.7

6.3

u/ml

963.5

2864.7

0.49

349

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

161

1.06

0.06

1.5

1.1

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

116

1.07

0.06

1.0

u/ml

0.5

0.2

0.33

(3036048) Francisella tularensis Ab [Titer] in Serum

112

749

0.98

0.06

1.2

titre

215.0

575.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

110

1.07

0.05

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

492

1.03

0.05

6.9

7.2

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.93

0.04

1.0

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

654

0.98

0.04

2.1

1.9

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.08

0.04

1.1

1.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

221

1438

1.01

0.02

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

221

1439

1.01

0.02

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2576

16899

1.00

0.02

2.1

1.9

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

212

1.02

0.00

1.3

1.4

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

207

1.01

0.00

1.6

1.4

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

220

1.01

0.00

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.99

0.00

2.6

2.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.03

0.00

1.3

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

104

684

1.00

0.00

2.4

2.6

ng/l

92.2

106.8

0.44

323

(3027974) Hepatitis B virus e Ag [Presence] in Serum

212

0.99

0.00

1.6

1.4

—

(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid

0.00

0.0

8.4

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

1.02

0.00

1.0

—

(3020132) Chylomicrons [Presence] in Serum or Plasma

0.00

0.0

1.8

—

(1175312) AMPAR1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(43054952) inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

9.4

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(1176058) AMPAR2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.99

0.00

1.0

—

(3022912) Hexacarboxylporphyrin [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3039179) Angiotensin converting enzyme [Enzymatic activity/volume] in Peritoneal fluid

0.00

0.0

1.0

—

(40771459) Voltage-gated potassium channel Ab [Moles/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint SLEEP and mortality.

Females

Parameter	HR [95% CI]	p-value
SLEEP	1.371 [1.23, 1.53]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.052

During the follow-up period (1.1.1998 — 31.12.2019), 7503 out of 98576 females with SLEEP died.

Males

Parameter	HR [95% CI]	p-value
SLEEP	1.298 [1.18, 1.42]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.01

During the follow-up period (1.1.1998 — 31.12.2019), 18538 out of 170389 males with SLEEP died.

Mortality risk

Mortality risk for people of age

years, who have SLEEP.

N-year risk	Females	Males
1	0.123%	0.276%
5	0.802%	1.401%
10	1.71%	3.613%
15	3.176%	6.971%
20	5.831%	12.18%

Relationships between endpoints

↥

Index endpoint: SLEEP – Sleep disorders (combined)

GWS hits: 33

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Sleep disorders (combined)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints